lolilo2107 personal page - To The Moon

lolilo2107

lolilo2107

No personal profile

105Follow

16Followers

0Topic

0Badge

2022-02-09

Good

Sorry, the original content has been removed

2021-02-11

$ARTIVISION TECHNOLOGIES LTD.(5NK.SI)$something wrong ...

2021-02-15

Give me 10 coin pls

Here's the formula for spotting genuinely undervalued companies, claims this investment house

2021-07-28

Good

Sorry, the original content has been removed

2021-02-19

Good but not for sg

Here's Why High Dividend Stocks Remain An Attractive Choice

2021-01-28

Oh noo

How GameStop’s surge recalls ghosts of past trading catastrophes

2021-06-12

Good

Sorry, the original content has been removed

2021-09-23

good

@laochiobu:$Palantir Technologies Inc.(PLTR)$some people ask me why don't I sell it when it's at its high at $25 before it drops any lower? Simple. If I haven't sold it at $26 why would I sell it now? Just because the price is dropping? Never look at the current price to measure the company's future.

2021-08-05

Can anyone explain, don't understand ....

Sorry, the original content has been removed

2021-06-15

Good

Fed Poised to Crawl Onto ‘Knife Edge’ to Rein In Record Largesse

2021-06-12

Good

Sorry, the original content has been removed

2021-02-16

Good

Walmart earnings, retail sales, and housing data: What to know in the week

2021-02-14

Nice

Here's the formula for spotting genuinely undervalued companies, claims this investment house

2021-01-22

Good ari stock

2022-01-11

Good !

7 Hot Stocks to Buy on Any Dip This Year

2021-09-01

good

@ARK女神:財報應該看什麼？教你幾招掌握閱讀財報的技巧

2021-06-15

Good

Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up

2021-02-16

Coin

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3556860469908509,"uuid":"3556860469908509","gmtCreate":1593766447285,"gmtModify":1611309364978,"name":"lolilo2107","pinyin":"lolilo2107","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":16,"headSize":105,"tweetSize":142,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.31","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.36%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.25%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9939467404,"gmtCreate":1662162530909,"gmtModify":1676537008596,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$</a>View on NASDAQ(.IXIC)BullishBearish","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$</a>View on NASDAQ(.IXIC)BullishBearish","text":"$NASDAQ(.IXIC)$View on NASDAQ(.IXIC)BullishBearish","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9939467404","isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9015618814,"gmtCreate":1649471432759,"gmtModify":1676534517930,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015618814","repostId":"9016857778","repostType":1,"repost":{"id":9016857778,"gmtCreate":1649170356019,"gmtModify":1676534462945,"author":{"id":"3563403080322781","authorId":"3563403080322781","name":"REIT_TIREMENT","avatar":"https://community-static.tradeup.com/news/381ca0896f0eb590f2877daa435bff15","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"title":"Top 10 Singapore REITs with the Highest YTD Returns in 2022 Q1","htmlText":"<a target=\"_blank\" href=\"https://ttm.financial/S/A17U.SI\">$ASCENDAS REAL ESTATE INV TRUST(A17U.SI)$</a>&nbsp;<a target=\"_blank\" href=\"https://ttm.financial/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>&nbsp;<a target=\"_blank\" href=\"https://ttm.financial/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>&nbsp;Photo by Kindel Media from PexelsAt the 2021 year-end, many expected 2022 would be a better year for economic recovery due to the easing of COVID-19 restrictions and more and more borders re-opening. However, due to the war between Russia and Ukraine, the recovery is affected. Fortunately, towards the end of March, most Singapore REITs have rallied upon the announcement of COVID-19 restriction easing and border opening. The first quarter of 2022 is a bumpy one for Singapore REITs, most a","listText":"<a target=\"_blank\" href=\"https://ttm.financial/S/A17U.SI\">$ASCENDAS REAL ESTATE INV TRUST(A17U.SI)$</a>&nbsp;<a target=\"_blank\" href=\"https://ttm.financial/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>&nbsp;<a target=\"_blank\" href=\"https://ttm.financial/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>&nbsp;Photo by Kindel Media from PexelsAt the 2021 year-end, many expected 2022 would be a better year for economic recovery due to the easing of COVID-19 restrictions and more and more borders re-opening. However, due to the war between Russia and Ukraine, the recovery is affected. Fortunately, towards the end of March, most Singapore REITs have rallied upon the announcement of COVID-19 restriction easing and border opening. The first quarter of 2022 is a bumpy one for Singapore REITs, most a","text":"$ASCENDAS REAL ESTATE INV TRUST(A17U.SI)$ $CapLand IntCom T(C38U.SI)$ $MAPLETREE LOGISTICS TRUST(M44U.SI)$ Photo by Kindel Media from PexelsAt the 2021 year-end, many expected 2022 would be a better year for economic recovery due to the easing of COVID-19 restrictions and more and more borders re-opening. However, due to the war between Russia and Ukraine, the recovery is affected. Fortunately, towards the end of March, most Singapore REITs have rallied upon the announcement of COVID-19 restriction easing and border opening. The first quarter of 2022 is a bumpy one for Singapore REITs, most a","images":[{"img":"https://community-static.tradeup.com/news/ec006cdbab97eadaa817a9a907ee2ba4"},{"img":"https://community-static.tradeup.com/news/2a1063d04e79cdec296371b78320a42b"},{"img":"https://community-static.tradeup.com/news/84fc864e7541367beadd06ca4dd48700"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016857778","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":7,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9034584236,"gmtCreate":1647920051906,"gmtModify":1676534280310,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Goood&nbsp;","listText":"Goood&nbsp;","text":"Goood","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9034584236","repostId":"9032765929","repostType":1,"repost":{"id":9032765929,"gmtCreate":1647445557254,"gmtModify":1676534231253,"author":{"id":"3563403080322781","authorId":"3563403080322781","name":"REIT_TIREMENT","avatar":"https://community-static.tradeup.com/news/381ca0896f0eb590f2877daa435bff15","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"title":"Singapore Retail Focused REITs Comparison @ 17 March 2022","htmlText":"<a target=\"_blank\" href=\"https://ttm.financial/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>&nbsp;<a target=\"_blank\" href=\"https://ttm.financial/S/J69U.SI\">$FRASERS CENTREPOINT TRUST(J69U.SI)$</a>&nbsp;<a target=\"_blank\" href=\"https://ttm.financial/S/SK6U.SI\">$SPH REIT(SK6U.SI)$</a>&nbsp;Below is the comparison for Singapore Retail Focused REITs based on the latest result, extracted from comparison tables on&nbsp;SREITs Data&nbsp;page:Image byphotosforyou from PixabayFundamental* Growth Trend for DPU is not adjusted for equity fundraising.REIT with the most number of green cells:1) Basic Profile &amp; Key Statistics - SGREIT2) Related Parties Shareholding - FCT &amp; SPH3) Lease Profile - CICT, SPH4) Debt Profile - CICT &amp; LREIT5) Diversification - CICT &amp; FCT6) Key Financial Metrics -","listText":"<a target=\"_blank\" href=\"https://ttm.financial/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>&nbsp;<a target=\"_blank\" href=\"https://ttm.financial/S/J69U.SI\">$FRASERS CENTREPOINT TRUST(J69U.SI)$</a>&nbsp;<a target=\"_blank\" href=\"https://ttm.financial/S/SK6U.SI\">$SPH REIT(SK6U.SI)$</a>&nbsp;Below is the comparison for Singapore Retail Focused REITs based on the latest result, extracted from comparison tables on&nbsp;SREITs Data&nbsp;page:Image byphotosforyou from PixabayFundamental* Growth Trend for DPU is not adjusted for equity fundraising.REIT with the most number of green cells:1) Basic Profile &amp; Key Statistics - SGREIT2) Related Parties Shareholding - FCT &amp; SPH3) Lease Profile - CICT, SPH4) Debt Profile - CICT &amp; LREIT5) Diversification - CICT &amp; FCT6) Key Financial Metrics -","text":"$CapLand IntCom T(C38U.SI)$ $FRASERS CENTREPOINT TRUST(J69U.SI)$ $SPH REIT(SK6U.SI)$ Below is the comparison for Singapore Retail Focused REITs based on the latest result, extracted from comparison tables on SREITs Data page:Image byphotosforyou from PixabayFundamental* Growth Trend for DPU is not adjusted for equity fundraising.REIT with the most number of green cells:1) Basic Profile & Key Statistics - SGREIT2) Related Parties Shareholding - FCT & SPH3) Lease Profile - CICT, SPH4) Debt Profile - CICT & LREIT5) Diversification - CICT & FCT6) Key Financial Metrics -","images":[{"img":"https://community-static.tradeup.com/news/e43dbc315c06c8b1b3e8c95e2979289d","width":"632","height":"1140"},{"img":"https://community-static.tradeup.com/news/0e613b8cea2ef064baa12de8bf5af1de","width":"632","height":"966"},{"img":"https://community-static.tradeup.com/news/775e8667df6fb52cb3d585a75c5c2fe0","width":"632","height":"421"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9032765929","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":5,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":880,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9096594378,"gmtCreate":1644417163550,"gmtModify":1676533923217,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9096594378","repostId":"1143631173","repostType":4,"isVote":1,"tweetType":1,"viewCount":710,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002902307,"gmtCreate":1641874722247,"gmtModify":1676533658096,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good !","listText":"Good !","text":"Good !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002902307","repostId":"1104925214","repostType":2,"repost":{"id":"1104925214","pubTimestamp":1641868694,"share":"https://www.laohu8.com/m/news/1104925214?lang=&edition=full","pubTime":"2022-01-11 10:38","market":"us","language":"en","title":"7 Hot Stocks to Buy on Any Dip This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1104925214","media":"InvestorPlace","summary":"An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock v","content":"<html><head></head><body><p>An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock valuations and now the super-contagious omicron variant of Covid-19. As a result, forecasting market performance for 2022 seems more difficult than it’s been in previous years. Right now, it looks like the market is priced to perfection with a slim margin of error. Therefore, investors could benefit by keeping an eye on hot stocks.</p><p>Since March 2020, the bull market has seen returns of nearly 110% in the <b>S&amp;P 500</b>Index. Despite such a remarkable rally, we need to highlight that 93% of the index saw a selloff of more than 10% in 2021.</p><p>While Wells Fargo predicts that the S&amp;P 500 index could hit 5,300, Morgan Stanley has a bearish outlook with a year-end 2022 target for 4,400. That suggest a decline of more than 4% from current levels.</p><p>Amidst so much uncertainty, market analysts have expressed conflicting opinions about where investor gains in the new year may come from. Market forecasts for 2022 might ultimately rely on correctly forecasting how the pandemic evolves. “The pathof the economy continues to depend on the course of the virus,” the Federal Open Market Committee’s stated following the Federal Reserve meeting in December.</p><p>With that information, here are seven hot stocks that offer substantial upside to any investor portfolio in 2022:</p><ul><li><b>Analog Devices</b>(NASDAQ:<b>ADI</b>)</li><li><b>Applied Materials</b>(NASDAQ:<b>AMAT</b>)</li><li><b>Charles Schwab</b>(NYSE:<b>SCHW</b>)</li><li><b>Dupont De Nemours</b> (NYSE:<b>DD</b>)</li><li><b>Fisker</b> (NYSE:<b>FSR</b>)</li><li><b>Unity Software</b>(NYSE:<b>U</b>)</li><li><b>USCF Midstream Energy Income Fund</b>(NYSEARCA:<b>UMI</b>)</li></ul><p><b>Hot Stocks: Analog Devices</b>(ADI)</p><p><b>52-week range:</b>$142.25 – $191.95</p><p><b>Dividend yield:</b>1.6%</p><p>Leading our list of hot stocks to watch is Wilmington, Massachusetts-based Analog Devices. The company manufactures chips that leverage high-performance analog, mixed-signal and digital signal processing technology. The chipmaker has a leading market share in converter chips that translate analog signals to digital and vice versa.</p><p>Analog Devices announced fourth-quarter 2021 results on Nov. 23, 2021. Revenue increased 53% year-over-year (YOY) to $2.34 billion. Adjusted earnings increased from $1.44 per share to $1.73 per share. The chipmaker generated a free cash flow of $810 million during the period. Cash and equivalents ended the quarter at $1.98 billion.</p><p>On the metrics, CEO Vincent Roche said, “ADI delivered another quarter of record revenue and profits, marking a strong end to the fiscal year. Our Industrial and Automotive markets reached all-time highs and our Consumer business returned to solid growth in fiscal 2021.”</p><p>The chipmaker continues to expand its manufacturing capacity to meet the rising demand for its cutting-edge chips. In fact, Analog received more orders than it could fill during the past year, leading to a solid backlog for its products. Moreover, it has recently completed the acquisition of Maxim Integrated, further solidifying its position as a semiconductor leader.</p><p>Most of Analog’s revenue comes from the industrial and automotive markets. Factory automation is driving surging demand for sensors and connectivity options for machines, all of which require the use of ADI’s chips. Furthermore, the automotive industry’s demand for chips continues to grow rapidly due to the increasing popularity of electric vehicles(EVs).</p><p>Currently, ADI stock hovers just below $170 per share, up nearly 8% over the past 12 months. Shares are trading at 24 times forward earnings and 10 times trailing sales. The 12-month median price forecast for Analog Devicesstands at $210.</p><p><b>Applied Materials</b>(AMAT)</p><p><b>52-week range:</b>$94.18 – $163.02</p><p><b>Dividend yield:</b>0.6%</p><p>When it comes to semiconductor manufacturing equipment, the one company that tops the list is the Santa Clara, California-based Applied Materials. It iswell-known for materials and engineering solutions.</p><p>Applied Materials released Q4 2021 results in mid-November. It reported a record quarterly revenue of $6.12 billion, up 31% YOY. Adjusted net income came in at $1.76 billion, or $1.94 per diluted share, up 53% YOY from $1.15 billion, or $1.25 per diluted share, in the prior-year quarter.</p><p>“Applied delivered strong growth in fiscal 2021, with overall orders up by 62 percent year over year and Semiconductor Systems orders up 78 percent,” remarked CFO Bob Halliday. “The momentum continued as our Semiconductor Systems backlog increased during the fourth quarter from $5.5 billion to $6.7 billion, and we see this strength sustaining into 2022.”</p><p>The company stands to benefit from crucial high-growth trends, including artificial intelligence, 5G, cloud computing, the Internet of Things (IoT) and autonomous driving. In particular, Applied Materials continues to gain significant market share in process control, including wafer inspection and e-beam technology. Demand for these services should keep AMAT on your list of hot stocks to watch.</p><p>In addition, Applied Materials plays a vital role in the U.S. tech industry. The lion’s share of global chip manufacturing is based in Taiwan, so the U.S. and Europe are looking to expand their domestic chip manufacturing capabilities. This implies significant long-term growth opportunities for equipment suppliers like Applied Materials.</p><p>At present, AMAT stock is priced around $145. Over the past 12 months, it has surged 53%. Given the rising global demand for foundry and logic capacity, the company has a moderate valuation at 18.7 times forward earnings and 6.1 times trailing sales. The 12-month median price forecast for Applied Materials stock stands at $174.</p><p><b>Hot Stocks: Charles Schwab</b>(SCHW)</p><p><b>52-week range:</b>$50.77 – $92.32</p><p><b>Dividend yield:</b>0.8%</p><p>In addition to brokerage services, the San Francisco, California-based Charles Schwab offers asset management, wealth management, banking, and other financial advisory services. Currently,the group boasts about $8 trillion in client assets, nearly 33 million active brokerage accounts and more than 2 million corporate retirement plan participants.</p><p>Charles Schwab released Q3 2021 results in mid-October. Revenue surged 87% YOY to $4.57 billion. Further, adjusted net income grew 130% to $1.72 billion, or 84 cents per diluted share, up from $749 million, or 51 cents per diluted share, a year ago.</p><p>On the results, CEO Walt Bettinger remarked, “We generated core net new assets of $139.0 billion in the quarter, pushing asset gathering for the first nine months of the year to $396.0 billion, representing an 8% annualized organic growth rate. Total client assets ended September at $7.61 trillion, up from $6.69 trillion at year-end 2020.”</p><p>In 2021, the increase in assets contributed to high growth. Now Wall Street concurs that Schwab should benefit from rising interest rates in 2022. Net interest revenue accounted for around 45% of total revenue in Q3.</p><p>Considering the anticipated increase in interest rates and Schwab’s powerful organic growth potential, many investors are following SCHW stock closely. It currently hovers in $90 territory, and over the past 12 months, the stock price has jumped 54%. SCHW is trading at 23.3 times forward earnings and 8.5 times trailing sales. The 12-month median price forecast for Charles Schwab stock stands at $95.50.</p><p><b>Dupont De Nemours</b> (DD)</p><p><b>52-week range:</b>$66.37 – $87.27</p><p><b>Dividend yield:</b>1.44%</p><p>DuPont de Nemours is one of the largest chemical and specialty materials companies worldwide. It provides many synthetic components that serve automotive, electronics, construction, safety and water management industries.</p><p>The company released Q3 2021 results in early November. Revenue for the period totaled $4.3 billion, up 18% YOY. Net income stood at $391 million, or 75 cents per diluted share, compared to a net loss of $79 million, or a loss of 11 cents loss per diluted share, in the prior-year quarter. Dupont generated a free cash flow of $634 million during the quarter. Cash and equivalents ended the quarter at $1.67 billion.</p><p>DuPont is going through a transition period, shifting its focus from low-margin chemical businesses to higher-margin opportunities in sectors with long-term growth potential. In November, management announced the acquisitionof<b>Rogers Corporation</b> for $5.2 billion.</p><p>This acquisition allows DuPont to gain exposure to secular high-growth markets, including electric vehicles, 5G and clean energy. Meanwhile, DuPont plans to divest most of its Mobility &amp; Materials segment, including engineering polymers and performance resins products lines.</p><p>On the acquisition, CEO Ed Breen remarked, “Today we also separately announced a definitive agreement to acquire Rogers Corporation, an advanced materials provider with superior technology innovation, applications engineering expertise, and leading end-market positions.”</p><p>DD stock is currently priced just below $82 per share, up 2% in the past 12 months. Shares are trading at 16.5 times forward earnings and 2.2 times trailing sales. The 12-month median price forecast for DuPont stock stands at $96.</p><p><b>Hot Stocks: Fisker</b> (FSR)</p><p><b>52-week range:</b>$9.61 – $31.96</p><p>Manhattan Beach, California-based Fisker is a pre-revenue EV name that made its market debut in 2020. It has a unique asset-light business model based on contract manufacturing.</p><p>Fisker released Q3 2021 results in early November. Net loss for the period totaled $110 million, or a loss of 37 cents per share, compared to a net loss of $40 million in the previous year. Cash and equivalents ended the quarter at $1.4 billion.</p><p>After the announcement, CEO Henrik Fisker noted, “We continued to make rapid progress in Q3 2021 on our core focus, achieving program milestones that ensure we execute Fisker Ocean SUV on-time and with several segment-leading features.”</p><p>Production for the Fisker Ocean, a mid-size premium SUV, is set to begin in November. The EV will be available to consumers through a leasing package that costs $37,499, making it one of the most affordable EVs on the market. Fisker Ocean reservations are expected to increase in 2022 with the opening of experience centers.</p><p>The Ocean is sold exclusively through the Fisker app or website without a dealer network. As a result, Wall Street is interested in its low overhead costs. Further, contract manufacturing should allow the company to enhance its EV portfolio without investing in risky manufacturing capacity.</p><p>Understandably, without revenues, Fisker is a speculative EV play. FSR stock hovers in $15 territory, up 2% over the past year. The 12-month median price forecast for Fisker stock stands at $25.50.</p><p><b>Unity Software</b>(U)</p><p><b>52-week range:</b>$76 – $210</p><p>Unity Software offers a software platform for developing interactive experiences and creating computer-generated visuals. The company is well-known for providing an engine for video games that work across computers, consoles, smart phones and virtual reality (VR) devices.</p><p>Unity reported Q3 2021 results in early November. Revenue soared 43% YOY to $286 million. But non-GAAP loss widened to $12.1 million, or 6 cents per diluted share, compared to a loss of $8.4 million, or 9 cents per diluted share, in the previous year. Cash and equivalents ended the period at $755 million.</p><p>On the results, CEO John Riccitiello remarked, “Unity’s strong performance this quarter was driven by innovation in data science, vertical growth and making significant strides in bringing RT3D technologies and tools to as many creators and artists as possible.”</p><p>Wall Street agrees Unity should benefit from the development of the metaverse. It is swiftly gaining a solid foothold in the VR and augmented reality (AR) markets. Around 60% of all games built for AR and VR are currently utilizing its engine services.</p><p>Moreover, Unity has recently acquired the visual-effects studioWeta Digital. This new business could soon enable the company to offer digital-effects services for film, games and television.</p><p>Unity hit an all-time high of $210 in mid-November. However, it currently trades around $125, down 13% over the past year. Shares are trading at 39x trailing sales. The 12-month median price forecast for Unity stock stands at $185.</p><p><b>Hot Stocks: USCF Midstream Energy Income Fund</b>(UMI)</p><p><b>52-Week Range:</b> $24.32 – $32.62</p><p><b>Expense Ratio:</b> 0.85% per year</p><p>Closing out this list of hot stocks to monitor is the USCF Midstream Energy Income Fund, an exchange-traded fund (ETF).It invests in U.S. and Canadian midstream energy companies, including master limited partnerships (MLPs). These energy infrastructure companies focus on transportation, storage, gathering and processing of energy.</p><p>UMI, which started trading in March 2021, has24 holdings. Fund managers choose companies based on their income growth, balance sheet strength, distribution (or dividend) coverage and contract quality. Exposure to commodity prices is also important as it can impact share prices, especially in the short run.</p><p>The top 10 names account for around 65% of net assets of $125.2 million. Among the leading names on the roster are <b>Targa Resources</b>(NYSE:<b><u>TRGP</u></b>),<b>Enbridge</b>(NYSE:<b><u>ENB</u></b>) and <b>Enterprise Products Partners</b>(NYSE:<b><u>EPD</u></b>).</p><p>Robust MLPs with quality contracts and solid fundamental metrics tend to be cash cows that most investors love. Since its inception in March 2020, UMI has soared more than 20% and saw a record high of $32.62 in mid-October. Interested investors should consider buying at $28.50.</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Hot Stocks to Buy on Any Dip This Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Hot Stocks to Buy on Any Dip This Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-11 10:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/01/7-hot-stocks-to-buy-on-any-dip-this-year/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock valuations and now the super-contagious omicron variant of Covid-19. As a result, forecasting market ...</p>\n\n<a href=\"https://investorplace.com/2022/01/7-hot-stocks-to-buy-on-any-dip-this-year/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FSR":"菲斯克","U":"Unity Software Inc.","DD":"杜邦","ADI":"亚德诺","UMI":"USCF Midstream Energy Income Fund","SCHW":"嘉信理财","ADMT":"ADM Tronics Unlimited, Inc."},"source_url":"https://investorplace.com/2022/01/7-hot-stocks-to-buy-on-any-dip-this-year/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104925214","content_text":"An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock valuations and now the super-contagious omicron variant of Covid-19. As a result, forecasting market performance for 2022 seems more difficult than it’s been in previous years. Right now, it looks like the market is priced to perfection with a slim margin of error. Therefore, investors could benefit by keeping an eye on hot stocks.Since March 2020, the bull market has seen returns of nearly 110% in the S&P 500Index. Despite such a remarkable rally, we need to highlight that 93% of the index saw a selloff of more than 10% in 2021.While Wells Fargo predicts that the S&P 500 index could hit 5,300, Morgan Stanley has a bearish outlook with a year-end 2022 target for 4,400. That suggest a decline of more than 4% from current levels.Amidst so much uncertainty, market analysts have expressed conflicting opinions about where investor gains in the new year may come from. Market forecasts for 2022 might ultimately rely on correctly forecasting how the pandemic evolves. “The pathof the economy continues to depend on the course of the virus,” the Federal Open Market Committee’s stated following the Federal Reserve meeting in December.With that information, here are seven hot stocks that offer substantial upside to any investor portfolio in 2022:Analog Devices(NASDAQ:ADI)Applied Materials(NASDAQ:AMAT)Charles Schwab(NYSE:SCHW)Dupont De Nemours (NYSE:DD)Fisker (NYSE:FSR)Unity Software(NYSE:U)USCF Midstream Energy Income Fund(NYSEARCA:UMI)Hot Stocks: Analog Devices(ADI)52-week range:$142.25 – $191.95Dividend yield:1.6%Leading our list of hot stocks to watch is Wilmington, Massachusetts-based Analog Devices. The company manufactures chips that leverage high-performance analog, mixed-signal and digital signal processing technology. The chipmaker has a leading market share in converter chips that translate analog signals to digital and vice versa.Analog Devices announced fourth-quarter 2021 results on Nov. 23, 2021. Revenue increased 53% year-over-year (YOY) to $2.34 billion. Adjusted earnings increased from $1.44 per share to $1.73 per share. The chipmaker generated a free cash flow of $810 million during the period. Cash and equivalents ended the quarter at $1.98 billion.On the metrics, CEO Vincent Roche said, “ADI delivered another quarter of record revenue and profits, marking a strong end to the fiscal year. Our Industrial and Automotive markets reached all-time highs and our Consumer business returned to solid growth in fiscal 2021.”The chipmaker continues to expand its manufacturing capacity to meet the rising demand for its cutting-edge chips. In fact, Analog received more orders than it could fill during the past year, leading to a solid backlog for its products. Moreover, it has recently completed the acquisition of Maxim Integrated, further solidifying its position as a semiconductor leader.Most of Analog’s revenue comes from the industrial and automotive markets. Factory automation is driving surging demand for sensors and connectivity options for machines, all of which require the use of ADI’s chips. Furthermore, the automotive industry’s demand for chips continues to grow rapidly due to the increasing popularity of electric vehicles(EVs).Currently, ADI stock hovers just below $170 per share, up nearly 8% over the past 12 months. Shares are trading at 24 times forward earnings and 10 times trailing sales. The 12-month median price forecast for Analog Devicesstands at $210.Applied Materials(AMAT)52-week range:$94.18 – $163.02Dividend yield:0.6%When it comes to semiconductor manufacturing equipment, the one company that tops the list is the Santa Clara, California-based Applied Materials. It iswell-known for materials and engineering solutions.Applied Materials released Q4 2021 results in mid-November. It reported a record quarterly revenue of $6.12 billion, up 31% YOY. Adjusted net income came in at $1.76 billion, or $1.94 per diluted share, up 53% YOY from $1.15 billion, or $1.25 per diluted share, in the prior-year quarter.“Applied delivered strong growth in fiscal 2021, with overall orders up by 62 percent year over year and Semiconductor Systems orders up 78 percent,” remarked CFO Bob Halliday. “The momentum continued as our Semiconductor Systems backlog increased during the fourth quarter from $5.5 billion to $6.7 billion, and we see this strength sustaining into 2022.”The company stands to benefit from crucial high-growth trends, including artificial intelligence, 5G, cloud computing, the Internet of Things (IoT) and autonomous driving. In particular, Applied Materials continues to gain significant market share in process control, including wafer inspection and e-beam technology. Demand for these services should keep AMAT on your list of hot stocks to watch.In addition, Applied Materials plays a vital role in the U.S. tech industry. The lion’s share of global chip manufacturing is based in Taiwan, so the U.S. and Europe are looking to expand their domestic chip manufacturing capabilities. This implies significant long-term growth opportunities for equipment suppliers like Applied Materials.At present, AMAT stock is priced around $145. Over the past 12 months, it has surged 53%. Given the rising global demand for foundry and logic capacity, the company has a moderate valuation at 18.7 times forward earnings and 6.1 times trailing sales. The 12-month median price forecast for Applied Materials stock stands at $174.Hot Stocks: Charles Schwab(SCHW)52-week range:$50.77 – $92.32Dividend yield:0.8%In addition to brokerage services, the San Francisco, California-based Charles Schwab offers asset management, wealth management, banking, and other financial advisory services. Currently,the group boasts about $8 trillion in client assets, nearly 33 million active brokerage accounts and more than 2 million corporate retirement plan participants.Charles Schwab released Q3 2021 results in mid-October. Revenue surged 87% YOY to $4.57 billion. Further, adjusted net income grew 130% to $1.72 billion, or 84 cents per diluted share, up from $749 million, or 51 cents per diluted share, a year ago.On the results, CEO Walt Bettinger remarked, “We generated core net new assets of $139.0 billion in the quarter, pushing asset gathering for the first nine months of the year to $396.0 billion, representing an 8% annualized organic growth rate. Total client assets ended September at $7.61 trillion, up from $6.69 trillion at year-end 2020.”In 2021, the increase in assets contributed to high growth. Now Wall Street concurs that Schwab should benefit from rising interest rates in 2022. Net interest revenue accounted for around 45% of total revenue in Q3.Considering the anticipated increase in interest rates and Schwab’s powerful organic growth potential, many investors are following SCHW stock closely. It currently hovers in $90 territory, and over the past 12 months, the stock price has jumped 54%. SCHW is trading at 23.3 times forward earnings and 8.5 times trailing sales. The 12-month median price forecast for Charles Schwab stock stands at $95.50.Dupont De Nemours (DD)52-week range:$66.37 – $87.27Dividend yield:1.44%DuPont de Nemours is one of the largest chemical and specialty materials companies worldwide. It provides many synthetic components that serve automotive, electronics, construction, safety and water management industries.The company released Q3 2021 results in early November. Revenue for the period totaled $4.3 billion, up 18% YOY. Net income stood at $391 million, or 75 cents per diluted share, compared to a net loss of $79 million, or a loss of 11 cents loss per diluted share, in the prior-year quarter. Dupont generated a free cash flow of $634 million during the quarter. Cash and equivalents ended the quarter at $1.67 billion.DuPont is going through a transition period, shifting its focus from low-margin chemical businesses to higher-margin opportunities in sectors with long-term growth potential. In November, management announced the acquisitionofRogers Corporation for $5.2 billion.This acquisition allows DuPont to gain exposure to secular high-growth markets, including electric vehicles, 5G and clean energy. Meanwhile, DuPont plans to divest most of its Mobility & Materials segment, including engineering polymers and performance resins products lines.On the acquisition, CEO Ed Breen remarked, “Today we also separately announced a definitive agreement to acquire Rogers Corporation, an advanced materials provider with superior technology innovation, applications engineering expertise, and leading end-market positions.”DD stock is currently priced just below $82 per share, up 2% in the past 12 months. Shares are trading at 16.5 times forward earnings and 2.2 times trailing sales. The 12-month median price forecast for DuPont stock stands at $96.Hot Stocks: Fisker (FSR)52-week range:$9.61 – $31.96Manhattan Beach, California-based Fisker is a pre-revenue EV name that made its market debut in 2020. It has a unique asset-light business model based on contract manufacturing.Fisker released Q3 2021 results in early November. Net loss for the period totaled $110 million, or a loss of 37 cents per share, compared to a net loss of $40 million in the previous year. Cash and equivalents ended the quarter at $1.4 billion.After the announcement, CEO Henrik Fisker noted, “We continued to make rapid progress in Q3 2021 on our core focus, achieving program milestones that ensure we execute Fisker Ocean SUV on-time and with several segment-leading features.”Production for the Fisker Ocean, a mid-size premium SUV, is set to begin in November. The EV will be available to consumers through a leasing package that costs $37,499, making it one of the most affordable EVs on the market. Fisker Ocean reservations are expected to increase in 2022 with the opening of experience centers.The Ocean is sold exclusively through the Fisker app or website without a dealer network. As a result, Wall Street is interested in its low overhead costs. Further, contract manufacturing should allow the company to enhance its EV portfolio without investing in risky manufacturing capacity.Understandably, without revenues, Fisker is a speculative EV play. FSR stock hovers in $15 territory, up 2% over the past year. The 12-month median price forecast for Fisker stock stands at $25.50.Unity Software(U)52-week range:$76 – $210Unity Software offers a software platform for developing interactive experiences and creating computer-generated visuals. The company is well-known for providing an engine for video games that work across computers, consoles, smart phones and virtual reality (VR) devices.Unity reported Q3 2021 results in early November. Revenue soared 43% YOY to $286 million. But non-GAAP loss widened to $12.1 million, or 6 cents per diluted share, compared to a loss of $8.4 million, or 9 cents per diluted share, in the previous year. Cash and equivalents ended the period at $755 million.On the results, CEO John Riccitiello remarked, “Unity’s strong performance this quarter was driven by innovation in data science, vertical growth and making significant strides in bringing RT3D technologies and tools to as many creators and artists as possible.”Wall Street agrees Unity should benefit from the development of the metaverse. It is swiftly gaining a solid foothold in the VR and augmented reality (AR) markets. Around 60% of all games built for AR and VR are currently utilizing its engine services.Moreover, Unity has recently acquired the visual-effects studioWeta Digital. This new business could soon enable the company to offer digital-effects services for film, games and television.Unity hit an all-time high of $210 in mid-November. However, it currently trades around $125, down 13% over the past year. Shares are trading at 39x trailing sales. The 12-month median price forecast for Unity stock stands at $185.Hot Stocks: USCF Midstream Energy Income Fund(UMI)52-Week Range: $24.32 – $32.62Expense Ratio: 0.85% per yearClosing out this list of hot stocks to monitor is the USCF Midstream Energy Income Fund, an exchange-traded fund (ETF).It invests in U.S. and Canadian midstream energy companies, including master limited partnerships (MLPs). These energy infrastructure companies focus on transportation, storage, gathering and processing of energy.UMI, which started trading in March 2021, has24 holdings. Fund managers choose companies based on their income growth, balance sheet strength, distribution (or dividend) coverage and contract quality. Exposure to commodity prices is also important as it can impact share prices, especially in the short run.The top 10 names account for around 65% of net assets of $125.2 million. Among the leading names on the roster are Targa Resources(NYSE:TRGP),Enbridge(NYSE:ENB) and Enterprise Products Partners(NYSE:EPD).Robust MLPs with quality contracts and solid fundamental metrics tend to be cash cows that most investors love. Since its inception in March 2020, UMI has soared more than 20% and saw a record high of $32.62 in mid-October. Interested investors should consider buying at $28.50.","news_type":1},"isVote":1,"tweetType":1,"viewCount":709,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863037060,"gmtCreate":1632329369350,"gmtModify":1676530755294,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863037060","repostId":"886642070","repostType":1,"repost":{"id":886642070,"gmtCreate":1631589353490,"gmtModify":1676530583868,"author":{"id":"3562905647872796","authorId":"3562905647872796","name":"laochiobu","avatar":"https://static.tigerbbs.com/5b3cab7c480557b2227750c4982e4860","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>some people ask me why don't I sell it when it's at its high at $25 before it drops any lower?&nbsp;Simple. If I haven't sold it at $26 why would I sell it now? Just because the price is dropping? Never look at the current price to measure the company's future.&nbsp;","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>some people ask me why don't I sell it when it's at its high at $25 before it drops any lower?&nbsp;Simple. If I haven't sold it at $26 why would I sell it now? Just because the price is dropping? Never look at the current price to measure the company's future.&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$some people ask me why don't I sell it when it's at its high at $25 before it drops any lower? Simple. If I haven't sold it at $26 why would I sell it now? Just because the price is dropping? Never look at the current price to measure the company's future.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/886642070","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816818466,"gmtCreate":1630486262755,"gmtModify":1676530316959,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/816818466","repostId":"813432346","repostType":1,"repost":{"id":813432346,"gmtCreate":1630227789685,"gmtModify":1676530247507,"author":{"id":"3561958952819268","authorId":"3561958952819268","name":"ARK女神","avatar":"https://static.tigerbbs.com/3f4dec49acccdeef585e67230709521a","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"title":"財報應該看什麼？教你幾招掌握閱讀財報的技巧","htmlText":"投資者爲什麼一定要會看財報？直接出錢投資不就好了嗎？如果你也抱着同樣的想法，對每個季度發佈的季報和每年發佈的年報視若無睹的話，你可能虧了錢都不知道爲什麼錢會沒了。財報，顯示了公司的財務和經營狀況。你不認識公司的CEO或管理層沒關係，至少你要學會通過分析財報來了解公司當下的發展狀況和成長空間，才能決定是否投資、投資更多，或者是及早離場。但是，密密麻麻的文字和數字，應該看什麼、怎麼看？今天，教你幾招掌握閱讀財報的技巧。上市公司必須按季度定期披露公司的經營情況，所以就有第一季度、第二季度（中期報告）、第三季度和第四季度。通常在公佈第四季度的同時，也會總結一整年的統計數據。從內容來看，季報會比較簡單，多數都會包含資產負債表、損益表和現金流量表三大報表。但是，有些公司會選擇不披露現金流量數據，這也很正常。年報是總結了一整年業績後所呈現給股東的報告。年報是經過會計師事務所審計過的，季報裏任何誤差會在年報裏糾正，所以可信程度上是最高的，提供的資料信息也是最全面的。【財報的時間】首先，大家必須知道每家公司的財政年度未必都是1月至12月。因此，要知道公司什麼時候會公佈季報或年報，投資者就得先了解公司的財政年度。舉個例子，如果公司的財政年度是2月至隔年1月，公司第一季度的財報涵蓋的就是2月至4月的業績報告，以此類推。每個季度結束後，公司有多少時間準備財報呢？每個國家的證監會給予上市公司遞交財報的時限略有不同，多數介於1-3個月之間。以美股爲例，美國證監會要求上市3年以上的公司，必須在每個季度結束後的35天之內遞交季度財報，在財政年度結束後的60天內遞交年報。【財報看點】1. 主席致辭 (Chairman’s Statement)「主席致辭」是年報裏應該重點閱讀的部分。主席會在這篇文章裏總結一些主要的財務數據，比如銷售額、盈利、客戶情況、股息等等。除此之外，也會重點介紹過去一年的企業活動、戰略、","listText":"投資者爲什麼一定要會看財報？直接出錢投資不就好了嗎？如果你也抱着同樣的想法，對每個季度發佈的季報和每年發佈的年報視若無睹的話，你可能虧了錢都不知道爲什麼錢會沒了。財報，顯示了公司的財務和經營狀況。你不認識公司的CEO或管理層沒關係，至少你要學會通過分析財報來了解公司當下的發展狀況和成長空間，才能決定是否投資、投資更多，或者是及早離場。但是，密密麻麻的文字和數字，應該看什麼、怎麼看？今天，教你幾招掌握閱讀財報的技巧。上市公司必須按季度定期披露公司的經營情況，所以就有第一季度、第二季度（中期報告）、第三季度和第四季度。通常在公佈第四季度的同時，也會總結一整年的統計數據。從內容來看，季報會比較簡單，多數都會包含資產負債表、損益表和現金流量表三大報表。但是，有些公司會選擇不披露現金流量數據，這也很正常。年報是總結了一整年業績後所呈現給股東的報告。年報是經過會計師事務所審計過的，季報裏任何誤差會在年報裏糾正，所以可信程度上是最高的，提供的資料信息也是最全面的。【財報的時間】首先，大家必須知道每家公司的財政年度未必都是1月至12月。因此，要知道公司什麼時候會公佈季報或年報，投資者就得先了解公司的財政年度。舉個例子，如果公司的財政年度是2月至隔年1月，公司第一季度的財報涵蓋的就是2月至4月的業績報告，以此類推。每個季度結束後，公司有多少時間準備財報呢？每個國家的證監會給予上市公司遞交財報的時限略有不同，多數介於1-3個月之間。以美股爲例，美國證監會要求上市3年以上的公司，必須在每個季度結束後的35天之內遞交季度財報，在財政年度結束後的60天內遞交年報。【財報看點】1. 主席致辭 (Chairman’s Statement)「主席致辭」是年報裏應該重點閱讀的部分。主席會在這篇文章裏總結一些主要的財務數據，比如銷售額、盈利、客戶情況、股息等等。除此之外，也會重點介紹過去一年的企業活動、戰略、","text":"投資者爲什麼一定要會看財報？直接出錢投資不就好了嗎？如果你也抱着同樣的想法，對每個季度發佈的季報和每年發佈的年報視若無睹的話，你可能虧了錢都不知道爲什麼錢會沒了。財報，顯示了公司的財務和經營狀況。你不認識公司的CEO或管理層沒關係，至少你要學會通過分析財報來了解公司當下的發展狀況和成長空間，才能決定是否投資、投資更多，或者是及早離場。但是，密密麻麻的文字和數字，應該看什麼、怎麼看？今天，教你幾招掌握閱讀財報的技巧。上市公司必須按季度定期披露公司的經營情況，所以就有第一季度、第二季度（中期報告）、第三季度和第四季度。通常在公佈第四季度的同時，也會總結一整年的統計數據。從內容來看，季報會比較簡單，多數都會包含資產負債表、損益表和現金流量表三大報表。但是，有些公司會選擇不披露現金流量數據，這也很正常。年報是總結了一整年業績後所呈現給股東的報告。年報是經過會計師事務所審計過的，季報裏任何誤差會在年報裏糾正，所以可信程度上是最高的，提供的資料信息也是最全面的。【財報的時間】首先，大家必須知道每家公司的財政年度未必都是1月至12月。因此，要知道公司什麼時候會公佈季報或年報，投資者就得先了解公司的財政年度。舉個例子，如果公司的財政年度是2月至隔年1月，公司第一季度的財報涵蓋的就是2月至4月的業績報告，以此類推。每個季度結束後，公司有多少時間準備財報呢？每個國家的證監會給予上市公司遞交財報的時限略有不同，多數介於1-3個月之間。以美股爲例，美國證監會要求上市3年以上的公司，必須在每個季度結束後的35天之內遞交季度財報，在財政年度結束後的60天內遞交年報。【財報看點】1. 主席致辭 (Chairman’s Statement)「主席致辭」是年報裏應該重點閱讀的部分。主席會在這篇文章裏總結一些主要的財務數據，比如銷售額、盈利、客戶情況、股息等等。除此之外，也會重點介紹過去一年的企業活動、戰略、","images":[{"img":"https://static.tigerbbs.com/08fcfde3cc5a7a8d6b08e442d2d7d9ff"},{"img":"https://static.tigerbbs.com/d22546566003092fb4ff75f87eeeef5c"},{"img":"https://static.tigerbbs.com/908edf3e8532a37de64032bd55e4a573"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813432346","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899053259,"gmtCreate":1628145103771,"gmtModify":1703502059207,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Can anyone explain, don't understand ....","listText":"Can anyone explain, don't understand ....","text":"Can anyone explain, don't understand ....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899053259","repostId":"2156164121","repostType":2,"isVote":1,"tweetType":1,"viewCount":104,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803792311,"gmtCreate":1627461981533,"gmtModify":1703490424431,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/803792311","repostId":"1116394171","repostType":4,"repost":{"id":"1116394171","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627459771,"share":"https://www.laohu8.com/m/news/1116394171?lang=&edition=full","pubTime":"2021-07-28 16:09","market":"us","language":"en","title":"Crypto stocks surged in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1116394171","media":"Tiger Newspress","summary":"Crypto stocks surged in premarket trading on bitcoin rising above $40,000.Bit Digital,The9,Ebang int","content":"<p>Crypto stocks surged in premarket trading&nbsp;on&nbsp;bitcoin rising above $40,000.Bit Digital,The9,Ebang&nbsp;international,Riot Blockchain,Marathon Digital Holdings&nbsp;and&nbsp;Canaan&nbsp;jumped between 5% and 15%.</p>\n<p><img src=\"https://static.tigerbbs.com/6f05ac6ce222ec430acc80b99ae1c8fc\" tg-width=\"374\" tg-height=\"364\" width=\"100%\" height=\"auto\"></p>\n<p>Bitcoin broke above $40,000 on Wednesday and headed for another attempt at breaking from its monthslong range as short sellers bailed out and traders drew confidence from recent positive comments about the cryptocurrency by high-profile investors.</p>\n<p>Bitcoin&nbsp;was last up 1.7% at $40,149 while rival cryptocurrency ether rose 1% to $2,328. Bitcoin is within a whisker of rising through its 100-day moving average.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Crypto stocks surged in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrypto stocks surged in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-28 16:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Crypto stocks surged in premarket trading&nbsp;on&nbsp;bitcoin rising above $40,000.Bit Digital,The9,Ebang&nbsp;international,Riot Blockchain,Marathon Digital Holdings&nbsp;and&nbsp;Canaan&nbsp;jumped between 5% and 15%.</p>\n<p><img src=\"https://static.tigerbbs.com/6f05ac6ce222ec430acc80b99ae1c8fc\" tg-width=\"374\" tg-height=\"364\" width=\"100%\" height=\"auto\"></p>\n<p>Bitcoin broke above $40,000 on Wednesday and headed for another attempt at breaking from its monthslong range as short sellers bailed out and traders drew confidence from recent positive comments about the cryptocurrency by high-profile investors.</p>\n<p>Bitcoin&nbsp;was last up 1.7% at $40,149 while rival cryptocurrency ether rose 1% to $2,328. Bitcoin is within a whisker of rising through its 100-day moving average.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BTBT":"Bit Digital, Inc.","RIOT":"Riot Platforms","MARA":"Marathon Digital Holdings Inc","CAN":"嘉楠科技","EBON":"亿邦国际","NCTY":"第九城市"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116394171","content_text":"Crypto stocks surged in premarket trading on bitcoin rising above $40,000.Bit Digital,The9,Ebang international,Riot Blockchain,Marathon Digital Holdings and Canaan jumped between 5% and 15%.\n\nBitcoin broke above $40,000 on Wednesday and headed for another attempt at breaking from its monthslong range as short sellers bailed out and traders drew confidence from recent positive comments about the cryptocurrency by high-profile investors.\nBitcoin was last up 1.7% at $40,149 while rival cryptocurrency ether rose 1% to $2,328. Bitcoin is within a whisker of rising through its 100-day moving average.","news_type":1},"isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166630297,"gmtCreate":1624005224019,"gmtModify":1703826337666,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166630297","repostId":"1107863941","repostType":4,"repost":{"id":"1107863941","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624004900,"share":"https://www.laohu8.com/m/news/1107863941?lang=&edition=full","pubTime":"2021-06-18 16:28","market":"us","language":"en","title":"CAI shares soared nearly 45% in pre-market，as it has agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=1107863941","media":"Tiger Newspress","summary":"CAI shares soared nearly 45% in pre-market，as it has agreed to a $1.1 billion takeover by Mitsubishi","content":"<p>CAI&nbsp;shares&nbsp;soared&nbsp;nearly&nbsp;45% in pre-market，as&nbsp;it has agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.</p>\n<p><img src=\"https://static.tigerbbs.com/a2922db8924ea9786a2bc69ae8bfc166\" tg-width=\"1289\" tg-height=\"605\" referrerpolicy=\"no-referrer\">The deal consists of $104 million worth of preferred stock and $986 million of common stock equity value, and has an enterprise value of $2.9 billion, CAI said on Thursday.</p>\n<p>Mitsubishi HC Capital has offered $56 per share in cash according to the company's statement, marking a 46.8% premium over CAI's last closing price.</p>\n<p>The deal has been unanimously approved by CAI's board of directors, the company said, adding that shares of CAI will no longer be listed on the New York Stock Exchange after the deal is completed.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CAI shares soared nearly 45% in pre-market，as it has agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCAI shares soared nearly 45% in pre-market，as it has agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CAI&nbsp;shares&nbsp;soared&nbsp;nearly&nbsp;45% in pre-market，as&nbsp;it has agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.</p>\n<p><img src=\"https://static.tigerbbs.com/a2922db8924ea9786a2bc69ae8bfc166\" tg-width=\"1289\" tg-height=\"605\" referrerpolicy=\"no-referrer\">The deal consists of $104 million worth of preferred stock and $986 million of common stock equity value, and has an enterprise value of $2.9 billion, CAI said on Thursday.</p>\n<p>Mitsubishi HC Capital has offered $56 per share in cash according to the company's statement, marking a 46.8% premium over CAI's last closing price.</p>\n<p>The deal has been unanimously approved by CAI's board of directors, the company said, adding that shares of CAI will no longer be listed on the New York Stock Exchange after the deal is completed.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAI":"CAI International Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107863941","content_text":"CAI shares soared nearly 45% in pre-market，as it has agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.\nThe deal consists of $104 million worth of preferred stock and $986 million of common stock equity value, and has an enterprise value of $2.9 billion, CAI said on Thursday.\nMitsubishi HC Capital has offered $56 per share in cash according to the company's statement, marking a 46.8% premium over CAI's last closing price.\nThe deal has been unanimously approved by CAI's board of directors, the company said, adding that shares of CAI will no longer be listed on the New York Stock Exchange after the deal is completed.","news_type":1},"isVote":1,"tweetType":1,"viewCount":145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166846059,"gmtCreate":1624003909771,"gmtModify":1703826289026,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166846059","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://www.laohu8.com/m/news/1142916683?lang=&edition=full","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169739970,"gmtCreate":1623850516890,"gmtModify":1703821343523,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/169739970","repostId":"169585538","repostType":1,"repost":{"id":169585538,"gmtCreate":1623843292821,"gmtModify":1703821095741,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/44a4f89726b3f6319d06a0075bf9ff76","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"留言送虎幣丨老虎證券七週年北京Open Day完美收官！","htmlText":"\n \n \n  7年前，當幾個年輕人在一間不到幾平米的屋子裏寫下第一行代碼時，他們可能還未想到7年後，這個App會被上百萬的用戶所喜愛，成爲他們投資全球的go to app。到今天，從客戶數、客戶資產到交易量，老虎不斷創下新高，而這一切最終都交匯到兩個字上：用戶，即你們。2月前，我們開始籌備這場見面，只爲了穿過一個個ID，與你們當面說聲謝謝。興奮和期待參雜着緊張，6月12日這場活動終於落地，邀請近200位虎友、7位投資大咖還有我們的創始人和技術負責人齊聚北京。一個下午的時間，點滴成於我們彌足珍貴的記憶，全是感動和感謝。我們看到，有頂着高溫從特意別城趕來、全神貫注地聽着分享的虎友；有相識熟稔、在座位裏熱聊暢談的虎友；更有在老虎年化達到300%，提問前還認真做了半頁紙“功課”的虎友。如下，讓我們一起用一些關鍵片段回顧這次有乾貨也夠有趣的見面。01“玩轉”投資下午1點不到，早有一些虎友陸續到達。在進入演講大廳前，首先迎來的是一條走廊，兩旁是老虎的成長史。這是我們首次以展覽的形式全方位呈現老虎業務。發展到今日，我們已不能用零售經紀券商一詞概之，還有投行、ESOP、財富管理、社區……成爲綜合型服務券商，是我們正在努力的方向。早在籌劃時，我們就將“有趣”定爲這次見面的關鍵詞。不僅在展示區，我們設置了比如“猜收益”、“猜下個暴漲股票”等小互動，我們還特意開闢出一片遊戲區。火爆的“眼疾手快”被我們搬到現場，背後的投資小建議是要合理管理持倉數量，不要把盤子鋪的太大。旁邊的“山地自行車”一踩，連接牆和地面的燈帶會隨之亮起，引得不少虎友一試身手。一定意義上，投資就像一場騎行，有上有下，也會碰到坑坑窪窪，但耐心與毅力或將是穿越週期的最好法寶。走到合照區，一個火箭、一個穿着太空服的小虎和“TO THE MOON”三個大字把很多虎友瞬間帶回年初散戶大戰華爾街時期。無疑，散戶力量正在崛起，而我們作爲散戶主戰場，絕不掉鏈\n \n","listText":"7年前，當幾個年輕人在一間不到幾平米的屋子裏寫下第一行代碼時，他們可能還未想到7年後，這個App會被上百萬的用戶所喜愛，成爲他們投資全球的go to app。到今天，從客戶數、客戶資產到交易量，老虎不斷創下新高，而這一切最終都交匯到兩個字上：用戶，即你們。2月前，我們開始籌備這場見面，只爲了穿過一個個ID，與你們當面說聲謝謝。興奮和期待參雜着緊張，6月12日這場活動終於落地，邀請近200位虎友、7位投資大咖還有我們的創始人和技術負責人齊聚北京。一個下午的時間，點滴成於我們彌足珍貴的記憶，全是感動和感謝。我們看到，有頂着高溫從特意別城趕來、全神貫注地聽着分享的虎友；有相識熟稔、在座位裏熱聊暢談的虎友；更有在老虎年化達到300%，提問前還認真做了半頁紙“功課”的虎友。如下，讓我們一起用一些關鍵片段回顧這次有乾貨也夠有趣的見面。01“玩轉”投資下午1點不到，早有一些虎友陸續到達。在進入演講大廳前，首先迎來的是一條走廊，兩旁是老虎的成長史。這是我們首次以展覽的形式全方位呈現老虎業務。發展到今日，我們已不能用零售經紀券商一詞概之，還有投行、ESOP、財富管理、社區……成爲綜合型服務券商，是我們正在努力的方向。早在籌劃時，我們就將“有趣”定爲這次見面的關鍵詞。不僅在展示區，我們設置了比如“猜收益”、“猜下個暴漲股票”等小互動，我們還特意開闢出一片遊戲區。火爆的“眼疾手快”被我們搬到現場，背後的投資小建議是要合理管理持倉數量，不要把盤子鋪的太大。旁邊的“山地自行車”一踩，連接牆和地面的燈帶會隨之亮起，引得不少虎友一試身手。一定意義上，投資就像一場騎行，有上有下，也會碰到坑坑窪窪，但耐心與毅力或將是穿越週期的最好法寶。走到合照區，一個火箭、一個穿着太空服的小虎和“TO THE MOON”三個大字把很多虎友瞬間帶回年初散戶大戰華爾街時期。無疑，散戶力量正在崛起，而我們作爲散戶主戰場，絕不掉鏈","text":"7年前，當幾個年輕人在一間不到幾平米的屋子裏寫下第一行代碼時，他們可能還未想到7年後，這個App會被上百萬的用戶所喜愛，成爲他們投資全球的go to app。到今天，從客戶數、客戶資產到交易量，老虎不斷創下新高，而這一切最終都交匯到兩個字上：用戶，即你們。2月前，我們開始籌備這場見面，只爲了穿過一個個ID，與你們當面說聲謝謝。興奮和期待參雜着緊張，6月12日這場活動終於落地，邀請近200位虎友、7位投資大咖還有我們的創始人和技術負責人齊聚北京。一個下午的時間，點滴成於我們彌足珍貴的記憶，全是感動和感謝。我們看到，有頂着高溫從特意別城趕來、全神貫注地聽着分享的虎友；有相識熟稔、在座位裏熱聊暢談的虎友；更有在老虎年化達到300%，提問前還認真做了半頁紙“功課”的虎友。如下，讓我們一起用一些關鍵片段回顧這次有乾貨也夠有趣的見面。01“玩轉”投資下午1點不到，早有一些虎友陸續到達。在進入演講大廳前，首先迎來的是一條走廊，兩旁是老虎的成長史。這是我們首次以展覽的形式全方位呈現老虎業務。發展到今日，我們已不能用零售經紀券商一詞概之，還有投行、ESOP、財富管理、社區……成爲綜合型服務券商，是我們正在努力的方向。早在籌劃時，我們就將“有趣”定爲這次見面的關鍵詞。不僅在展示區，我們設置了比如“猜收益”、“猜下個暴漲股票”等小互動，我們還特意開闢出一片遊戲區。火爆的“眼疾手快”被我們搬到現場，背後的投資小建議是要合理管理持倉數量，不要把盤子鋪的太大。旁邊的“山地自行車”一踩，連接牆和地面的燈帶會隨之亮起，引得不少虎友一試身手。一定意義上，投資就像一場騎行，有上有下，也會碰到坑坑窪窪，但耐心與毅力或將是穿越週期的最好法寶。走到合照區，一個火箭、一個穿着太空服的小虎和“TO THE MOON”三個大字把很多虎友瞬間帶回年初散戶大戰華爾街時期。無疑，散戶力量正在崛起，而我們作爲散戶主戰場，絕不掉鏈","images":[{"img":"https://static.tigerbbs.com/464e70063cff5b7b7b5b9d7d3d550e73","width":"0","height":"0"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/169585538","isVote":1,"tweetType":2,"object":{"id":"39e3640e0a094faf8ab3568799950829","tweetId":"169585538","videoUrl":"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/3005369a3701925919455986729/oPsNfUpbGHIA.mp4","poster":"https://static.tigerbbs.com/464e70063cff5b7b7b5b9d7d3d550e73"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":14,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":71,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187217517,"gmtCreate":1623755293239,"gmtModify":1704210638390,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187217517","repostId":"1167457915","repostType":4,"repost":{"id":"1167457915","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1623750756,"share":"https://www.laohu8.com/m/news/1167457915?lang=&edition=full","pubTime":"2021-06-15 17:52","market":"us","language":"en","title":"Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1167457915","media":"Benzinga","summary":"It was \"better late than never\" for Novavax, Inc.NVAX, as the biopharma finally got around to announ","content":"<p>It was \"better late than never\" for&nbsp;<b>Novavax, Inc.</b>NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.</p>\n<p>Here's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namely<b>Pfizer Inc.</b>PFE 0.05%-<b>BioNTech SE</b>BNTXand<b>Moderna, Inc.</b>MRNA, both of which have authorized vaccines in the market.</p>\n<p><b>Vaccine Type:</b>&nbsp;Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.</p>\n<p>The Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern&nbsp;vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.</p>\n<p>This spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.</p>\n<p>Novavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle&nbsp;that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.</p>\n<p><b>The Vaccine Doses:</b>&nbsp;The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.</p>\n<p>The interval between the two doses —&nbsp;the priming and booster dose —&nbsp;is 21 days each for Pfizer and Novavax and 28 days for Moderna.</p>\n<p><b>The Target Population:</b>&nbsp;The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants&nbsp;ages 16 years and older. The trial enrolled 43,448 participants.</p>\n<p>Moderna'sPhase 3 COVE study enrolled 30,000 participants&nbsp;ages 18 years and up.</p>\n<p>Since then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.</p>\n<p>Bothcompanieshave also initiated studies in the pediatric population.</p>\n<p>Novavax's study enrolled 29,960 participants&nbsp;18 years of age and older&nbsp;across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.</p>\n<p><b>Vaccine Logistics:</b>&nbsp;Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.</p>\n<p>Previously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five&nbsp;days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.</p>\n<p>NVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.</p>\n<p><b>Vaccine Efficacy:</b>&nbsp;Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven&nbsp;days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.</p>\n<p>The vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.</p>\n<p>Moderna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.</p>\n<p>Novavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.</p>\n<p>Against variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.</p>\n<p>Overall efficacy was 90.4%, meeting the primary endpoint.</p>\n<p><b>Cantor Fitzgerald On Novavax's Vaccine:</b>A differentiating factor for NVX-2373&nbsp;is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.</p>\n<p>\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.</p>\n<p>Showing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.</p>\n<p>This profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.</p>\n<p><b>Vaccine Safety Data:</b>Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from&nbsp;BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.</p>\n<p>For Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.</p>\n<p>Preliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.</p>\n<p>In assessing reactogenicity seven&nbsp;days after dose one&nbsp;and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-06-15 17:52</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>It was \"better late than never\" for&nbsp;<b>Novavax, Inc.</b>NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.</p>\n<p>Here's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namely<b>Pfizer Inc.</b>PFE 0.05%-<b>BioNTech SE</b>BNTXand<b>Moderna, Inc.</b>MRNA, both of which have authorized vaccines in the market.</p>\n<p><b>Vaccine Type:</b>&nbsp;Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.</p>\n<p>The Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern&nbsp;vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.</p>\n<p>This spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.</p>\n<p>Novavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle&nbsp;that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.</p>\n<p><b>The Vaccine Doses:</b>&nbsp;The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.</p>\n<p>The interval between the two doses —&nbsp;the priming and booster dose —&nbsp;is 21 days each for Pfizer and Novavax and 28 days for Moderna.</p>\n<p><b>The Target Population:</b>&nbsp;The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants&nbsp;ages 16 years and older. The trial enrolled 43,448 participants.</p>\n<p>Moderna'sPhase 3 COVE study enrolled 30,000 participants&nbsp;ages 18 years and up.</p>\n<p>Since then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.</p>\n<p>Bothcompanieshave also initiated studies in the pediatric population.</p>\n<p>Novavax's study enrolled 29,960 participants&nbsp;18 years of age and older&nbsp;across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.</p>\n<p><b>Vaccine Logistics:</b>&nbsp;Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.</p>\n<p>Previously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five&nbsp;days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.</p>\n<p>NVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.</p>\n<p><b>Vaccine Efficacy:</b>&nbsp;Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven&nbsp;days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.</p>\n<p>The vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.</p>\n<p>Moderna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.</p>\n<p>Novavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.</p>\n<p>Against variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.</p>\n<p>Overall efficacy was 90.4%, meeting the primary endpoint.</p>\n<p><b>Cantor Fitzgerald On Novavax's Vaccine:</b>A differentiating factor for NVX-2373&nbsp;is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.</p>\n<p>\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.</p>\n<p>Showing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.</p>\n<p>This profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.</p>\n<p><b>Vaccine Safety Data:</b>Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from&nbsp;BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.</p>\n<p>For Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.</p>\n<p>Preliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.</p>\n<p>In assessing reactogenicity seven&nbsp;days after dose one&nbsp;and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167457915","content_text":"It was \"better late than never\" for Novavax, Inc.NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.\nHere's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namelyPfizer Inc.PFE 0.05%-BioNTech SEBNTXandModerna, Inc.MRNA, both of which have authorized vaccines in the market.\nVaccine Type: Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.\nThe Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.\nThis spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.\nNovavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.\nThe Vaccine Doses: The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.\nThe interval between the two doses — the priming and booster dose — is 21 days each for Pfizer and Novavax and 28 days for Moderna.\nThe Target Population: The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants ages 16 years and older. The trial enrolled 43,448 participants.\nModerna'sPhase 3 COVE study enrolled 30,000 participants ages 18 years and up.\nSince then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.\nBothcompanieshave also initiated studies in the pediatric population.\nNovavax's study enrolled 29,960 participants 18 years of age and older across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.\nVaccine Logistics: Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.\nPreviously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.\nNVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.\nVaccine Efficacy: Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.\nThe vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.\nModerna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.\nNovavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.\nAgainst variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.\nOverall efficacy was 90.4%, meeting the primary endpoint.\nCantor Fitzgerald On Novavax's Vaccine:A differentiating factor for NVX-2373 is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.\n\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.\nShowing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.\nThis profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.\nVaccine Safety Data:Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.\nFor Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.\nPreliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.\nIn assessing reactogenicity seven days after dose one and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187214508,"gmtCreate":1623755269304,"gmtModify":1704210634683,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187214508","repostId":"1142697857","repostType":4,"repost":{"id":"1142697857","pubTimestamp":1623752468,"share":"https://www.laohu8.com/m/news/1142697857?lang=&edition=full","pubTime":"2021-06-15 18:21","market":"us","language":"en","title":"Fed Poised to Crawl Onto ‘Knife Edge’ to Rein In Record Largesse","url":"https://stock-news.laohu8.com/highlight/detail?id=1142697857","media":"Bloomberg","summary":"Fed wants to normalize relations with Congress, markets\nPolicy makers may begin months-long talks on","content":"<ul>\n <li>Fed wants to normalize relations with Congress, markets</li>\n <li>Policy makers may begin months-long talks on taper Tuesday</li>\n</ul>\n<p>The Federal Reserve is inching toward the start of a long road to normalizing its relationship with the rest of Washington and Wall Street.</p>\n<p>After spending the past 15 months providing unprecedented help to the federal government and investors via trillions of dollars of bond purchases, it could start preliminary discussions about scaling back that support at a pivotal two-day policy meeting that kicks off on Tuesday.</p>\n<p>Even so, actual steps in that direction by Chair Jerome Powell and his colleagues are likely still months off.</p>\n<p>Weaning Wall Street and Washington off the Fed’s extraordinary largesse won’t be easy. Since Covid-19 struck the U.S. in March 2020, the central bank has brought more than $2.5 trillion of U.S. Treasury debt, effectively covering more than half of the federal government’s red ink over that time.</p>\n<p><img src=\"https://static.tigerbbs.com/f845f5d5fa4baccad7e30207df549d71\" tg-width=\"620\" tg-height=\"348\">That buying -- together with about $870 billion in purchases of mortgage-backed securities -- has flooded the financial markets with liquidity, contributing to a doubling of the stock market from its pandemic low.</p>\n<p>“It will be like crawling along a knife-edge ridge,” former Bank of England policy maker Charles Goodhart said of the task facing the Fed. “If you do too little you’ll find inflation will just go on accelerating. If you do too much you get into a financial crisis and a recession.”</p>\n<p>Fed officials have said they want to see “substantial further progress” toward their goals of maximum employment and average 2% inflation before reducing current asset purchases of $120 billion per month. None are suggesting that they’re close to achieving that, though some have pressed for discussions to begin on a plan for tapering that buying.</p>\n<p>As Powell has pointed out more than once, payrolls are still substantially below where they were pre-pandemic -- some 7.6 million jobs short, according to the May employment report. And while inflation recently has proven surprisingly rapid -- consumer prices climbed 5% in May from a year earlier -- Powell and other Fed officials have argued that the rise is mostly transitory, the result of temporary bottlenecks as the economy reopens and low readings a year ago when it shut down.</p>\n<p><b>Price Pressures Heat Up</b></p>\n<p>U.S. core and headline inflation both increased more than forecast in May</p>\n<p><img src=\"https://static.tigerbbs.com/320b6b6419ac9bcbe999007f7786196f\" tg-width=\"643\" tg-height=\"330\">“Why would the Fed try to fix bottleneck-driven inflation by signaling earlier rate hikes and hitting demand?” Julia Coronado, president of MacroPolicy Perspectives, asked in a June 14 tweet.</p>\n<p>Instead, after years of falling short of their inflation goal, policy makers will “err on the side of patience” in scaling back stimulus, said former Fed official David Wilcox, who is now at the Peterson Institute for International Economics.</p>\n<p>Powell’s past and potential future also argue for patience. As a Fed governor in 2013, he was among those pushing then-Chairman Ben Bernanke to roll back quantitative easing, only to see the financial markets throw a “taper tantrum” at the mere suggestion such a policy shift was coming.</p>\n<p>With his own term as Fed chair up next February, Powell has an extra incentive to avoid a repeat of such turbulence.</p>\n<p>“While the Fed is an independent institution, its leadership, up for reappointment next year, could not totally ignore the dim view the administration and Democratic Congress would take toward a shift to a more pre-emptive policy stance,” Deutsche Bank chief economist David Folkerts-Landau and colleagues wrote in a June 7 report.</p>\n<p>Some three-quarters of economists surveyed by Bloomberg last week said they expect the Fed to announce between August and year-end that it will begin paring its purchases, with one-third forecasting it won’t fire the starting gun until December.</p>\n<p>It’s not just the timing of the taper that’s up for discussion. So too are its composition and pace.</p>\n<p>The Fed has faced criticism from within and outside the organization for continuing to buy $40 billion of mortgage-backed securities per month while house prices are surging. Vice Chair Randal Quarles said last month that the Fed would “certainly” look at that issue in the context of its taper discussions.</p>\n<p><b>Steady Pace</b></p>\n<p>The last time the Fed wound up a quantitative easing program, in 2014, it shrank its asset purchases at a steady pace.</p>\n<p>“Investors may be lulled into a false sense of security by that experience,” former Fed official William English told a June 8 Deutsche Bank webinar. Given all the uncertainty surrounding the post pandemic economy, “it’s not necessarily going to be the case that the Fed is going to taper in steady steps.”</p>\n<p>Much may depend on the financial markets. American Enterprise Institute resident fellow Desmond Lachman said the ultra-easy monetary policy being pursued by the Fed and other major central banks has led to an “everything asset price bubble,” with stock, credit and housing markets all frothy.</p>\n<p>“The chance of the bubble bursting is all the greater if the Fed is behind the curve,” he said.</p>\n<p>English, who is now at the Yale School of Management, said it’s going to be politically hard for the Fed to wind up its asset purchases and increase interest rates because that will boost the government’s borrowing costs.</p>\n<p>“The Fed is going to come under a lot of criticism for raising rates and making budget choices for the Congress considerably tougher,” he said, adding, “At some level, the Fed needs to both normalize policy but also normalize its relationship with the government.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed Poised to Crawl Onto ‘Knife Edge’ to Rein In Record Largesse</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed Poised to Crawl Onto ‘Knife Edge’ to Rein In Record Largesse\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 18:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-15/fed-poised-to-crawl-onto-knife-edge-to-rein-in-record-largesse><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Fed wants to normalize relations with Congress, markets\nPolicy makers may begin months-long talks on taper Tuesday\n\nThe Federal Reserve is inching toward the start of a long road to normalizing its ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-15/fed-poised-to-crawl-onto-knife-edge-to-rein-in-record-largesse\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-15/fed-poised-to-crawl-onto-knife-edge-to-rein-in-record-largesse","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142697857","content_text":"Fed wants to normalize relations with Congress, markets\nPolicy makers may begin months-long talks on taper Tuesday\n\nThe Federal Reserve is inching toward the start of a long road to normalizing its relationship with the rest of Washington and Wall Street.\nAfter spending the past 15 months providing unprecedented help to the federal government and investors via trillions of dollars of bond purchases, it could start preliminary discussions about scaling back that support at a pivotal two-day policy meeting that kicks off on Tuesday.\nEven so, actual steps in that direction by Chair Jerome Powell and his colleagues are likely still months off.\nWeaning Wall Street and Washington off the Fed’s extraordinary largesse won’t be easy. Since Covid-19 struck the U.S. in March 2020, the central bank has brought more than $2.5 trillion of U.S. Treasury debt, effectively covering more than half of the federal government’s red ink over that time.\nThat buying -- together with about $870 billion in purchases of mortgage-backed securities -- has flooded the financial markets with liquidity, contributing to a doubling of the stock market from its pandemic low.\n“It will be like crawling along a knife-edge ridge,” former Bank of England policy maker Charles Goodhart said of the task facing the Fed. “If you do too little you’ll find inflation will just go on accelerating. If you do too much you get into a financial crisis and a recession.”\nFed officials have said they want to see “substantial further progress” toward their goals of maximum employment and average 2% inflation before reducing current asset purchases of $120 billion per month. None are suggesting that they’re close to achieving that, though some have pressed for discussions to begin on a plan for tapering that buying.\nAs Powell has pointed out more than once, payrolls are still substantially below where they were pre-pandemic -- some 7.6 million jobs short, according to the May employment report. And while inflation recently has proven surprisingly rapid -- consumer prices climbed 5% in May from a year earlier -- Powell and other Fed officials have argued that the rise is mostly transitory, the result of temporary bottlenecks as the economy reopens and low readings a year ago when it shut down.\nPrice Pressures Heat Up\nU.S. core and headline inflation both increased more than forecast in May\n“Why would the Fed try to fix bottleneck-driven inflation by signaling earlier rate hikes and hitting demand?” Julia Coronado, president of MacroPolicy Perspectives, asked in a June 14 tweet.\nInstead, after years of falling short of their inflation goal, policy makers will “err on the side of patience” in scaling back stimulus, said former Fed official David Wilcox, who is now at the Peterson Institute for International Economics.\nPowell’s past and potential future also argue for patience. As a Fed governor in 2013, he was among those pushing then-Chairman Ben Bernanke to roll back quantitative easing, only to see the financial markets throw a “taper tantrum” at the mere suggestion such a policy shift was coming.\nWith his own term as Fed chair up next February, Powell has an extra incentive to avoid a repeat of such turbulence.\n“While the Fed is an independent institution, its leadership, up for reappointment next year, could not totally ignore the dim view the administration and Democratic Congress would take toward a shift to a more pre-emptive policy stance,” Deutsche Bank chief economist David Folkerts-Landau and colleagues wrote in a June 7 report.\nSome three-quarters of economists surveyed by Bloomberg last week said they expect the Fed to announce between August and year-end that it will begin paring its purchases, with one-third forecasting it won’t fire the starting gun until December.\nIt’s not just the timing of the taper that’s up for discussion. So too are its composition and pace.\nThe Fed has faced criticism from within and outside the organization for continuing to buy $40 billion of mortgage-backed securities per month while house prices are surging. Vice Chair Randal Quarles said last month that the Fed would “certainly” look at that issue in the context of its taper discussions.\nSteady Pace\nThe last time the Fed wound up a quantitative easing program, in 2014, it shrank its asset purchases at a steady pace.\n“Investors may be lulled into a false sense of security by that experience,” former Fed official William English told a June 8 Deutsche Bank webinar. Given all the uncertainty surrounding the post pandemic economy, “it’s not necessarily going to be the case that the Fed is going to taper in steady steps.”\nMuch may depend on the financial markets. American Enterprise Institute resident fellow Desmond Lachman said the ultra-easy monetary policy being pursued by the Fed and other major central banks has led to an “everything asset price bubble,” with stock, credit and housing markets all frothy.\n“The chance of the bubble bursting is all the greater if the Fed is behind the curve,” he said.\nEnglish, who is now at the Yale School of Management, said it’s going to be politically hard for the Fed to wind up its asset purchases and increase interest rates because that will boost the government’s borrowing costs.\n“The Fed is going to come under a lot of criticism for raising rates and making budget choices for the Congress considerably tougher,” he said, adding, “At some level, the Fed needs to both normalize policy but also normalize its relationship with the government.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187215932,"gmtCreate":1623755229026,"gmtModify":1704210632261,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187215932","repostId":"187236000","repostType":1,"repost":{"id":187236000,"gmtCreate":1623754908600,"gmtModify":1704210614839,"author":{"id":"3563421686188310","authorId":"3563421686188310","name":"Hopehope赋予希望","avatar":"https://community-static.tradeup.com/news/46495f44529967f5d3b4d03a47167f5b","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Xiaomi resilience today despite hang seng weakness. Will it be a market leader in internet of things?","listText":"Xiaomi resilience today despite hang seng weakness. Will it be a market leader in internet of things?","text":"Xiaomi resilience today despite hang seng weakness. Will it be a market leader in internet of things?","images":[{"img":"https://static.tigerbbs.com/8b36394737ef76c5abf601f7bd87cdee","width":"1080","height":"1683"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187236000","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187211769,"gmtCreate":1623755137851,"gmtModify":1704210628207,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187211769","repostId":"187236000","repostType":1,"repost":{"id":187236000,"gmtCreate":1623754908600,"gmtModify":1704210614839,"author":{"id":"3563421686188310","authorId":"3563421686188310","name":"Hopehope赋予希望","avatar":"https://community-static.tradeup.com/news/46495f44529967f5d3b4d03a47167f5b","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Xiaomi resilience today despite hang seng weakness. Will it be a market leader in internet of things?","listText":"Xiaomi resilience today despite hang seng weakness. Will it be a market leader in internet of things?","text":"Xiaomi resilience today despite hang seng weakness. Will it be a market leader in internet of things?","images":[{"img":"https://static.tigerbbs.com/8b36394737ef76c5abf601f7bd87cdee","width":"1080","height":"1683"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187236000","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185237114,"gmtCreate":1623651823838,"gmtModify":1704207863032,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/185237114","repostId":"185800004","repostType":1,"repost":{"id":185800004,"gmtCreate":1623639035308,"gmtModify":1704207554611,"author":{"id":"3556084865069319","authorId":"3556084865069319","name":"InvestKaki","avatar":"https://static.tigerbbs.com/b52586e012e48f17648ea31cf53bb10d","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"【新加坡】7 只值得關注的股票【2021 年 6 月】","htmlText":"5月新冠疫情捲土重來，因此這對新加坡來說是艱難的一個月份。新加坡加強疫情防控措施，限制小販中心和購物中心的人流。這些措施必定會對（尤其是零售和餐飲業）企業造成巨大沖擊。然而，仍有幾家公司能夠在艱難時期蓬勃發展，分析師對這些公司持樂觀態度。我們已經確定了 6月份您應當關注的 7只股票。#1 <a target=\"_blank\" href=\"https://laohu8.com/S/41A.SI\">$優格醫療保健有限公司(41A.SI)$</a>&nbsp;Phillips Capital維持對該公司的“買入”評級，目標股價 0.85新元。有兩個主要原因。一是該公司的毛利率十分亮眼。毛利率同比上漲兩倍多，達到 62.7%。得益於創紀錄的收益，現金也逐步增長。創紀錄的收益將淨現金從 2021財年第二季度的 3,250萬新元提高至 4,990萬新元。此外，該公司也有望將產能從 2021財年第三季度的 29億新元增加到 2022財年的 46億新元，增幅爲 58%。產能淨增量爲 17億新元，其中 5億新元已在 4月投產，剩餘 12億新元將從 2021年 7月開始投產。我們 2022財年收入增長預測基於產能激增。另一家工廠的產能擴張計劃將在最終確定後宣佈。#2城市發展有限公司大華繼顯維持對該公司的“買入”評級，目標股價 8.50新元。積極情緒的主要驅動力是其英國商業資產的 IPO潛力。我們瞭解到，全球第 11大主權財富基金卡塔爾投資局正尋求將其位於倫敦金絲雀碼頭（匯豐銀行總部所在地）的資產注入 CDL的英國商業房地產投資信託基金 (REIT)。我們從積極的角度看待這一發展形勢，因爲他們的舉措將壯大 REIT，引入長期投資者，併爲 REIT提供一項我們認爲具有很長加權平均租賃期的資產。由於新冠疫情影響，該 REIT的 IPO已從去年推遲到今年，目前預計會在 2021年第三季度進行。#3 P","listText":"5月新冠疫情捲土重來，因此這對新加坡來說是艱難的一個月份。新加坡加強疫情防控措施，限制小販中心和購物中心的人流。這些措施必定會對（尤其是零售和餐飲業）企業造成巨大沖擊。然而，仍有幾家公司能夠在艱難時期蓬勃發展，分析師對這些公司持樂觀態度。我們已經確定了 6月份您應當關注的 7只股票。#1 <a target=\"_blank\" href=\"https://laohu8.com/S/41A.SI\">$優格醫療保健有限公司(41A.SI)$</a>&nbsp;Phillips Capital維持對該公司的“買入”評級，目標股價 0.85新元。有兩個主要原因。一是該公司的毛利率十分亮眼。毛利率同比上漲兩倍多，達到 62.7%。得益於創紀錄的收益，現金也逐步增長。創紀錄的收益將淨現金從 2021財年第二季度的 3,250萬新元提高至 4,990萬新元。此外，該公司也有望將產能從 2021財年第三季度的 29億新元增加到 2022財年的 46億新元，增幅爲 58%。產能淨增量爲 17億新元，其中 5億新元已在 4月投產，剩餘 12億新元將從 2021年 7月開始投產。我們 2022財年收入增長預測基於產能激增。另一家工廠的產能擴張計劃將在最終確定後宣佈。#2城市發展有限公司大華繼顯維持對該公司的“買入”評級，目標股價 8.50新元。積極情緒的主要驅動力是其英國商業資產的 IPO潛力。我們瞭解到，全球第 11大主權財富基金卡塔爾投資局正尋求將其位於倫敦金絲雀碼頭（匯豐銀行總部所在地）的資產注入 CDL的英國商業房地產投資信託基金 (REIT)。我們從積極的角度看待這一發展形勢，因爲他們的舉措將壯大 REIT，引入長期投資者，併爲 REIT提供一項我們認爲具有很長加權平均租賃期的資產。由於新冠疫情影響，該 REIT的 IPO已從去年推遲到今年，目前預計會在 2021年第三季度進行。#3 P","text":"5月新冠疫情捲土重來，因此這對新加坡來說是艱難的一個月份。新加坡加強疫情防控措施，限制小販中心和購物中心的人流。這些措施必定會對（尤其是零售和餐飲業）企業造成巨大沖擊。然而，仍有幾家公司能夠在艱難時期蓬勃發展，分析師對這些公司持樂觀態度。我們已經確定了 6月份您應當關注的 7只股票。#1 $優格醫療保健有限公司(41A.SI)$ Phillips Capital維持對該公司的“買入”評級，目標股價 0.85新元。有兩個主要原因。一是該公司的毛利率十分亮眼。毛利率同比上漲兩倍多，達到 62.7%。得益於創紀錄的收益，現金也逐步增長。創紀錄的收益將淨現金從 2021財年第二季度的 3,250萬新元提高至 4,990萬新元。此外，該公司也有望將產能從 2021財年第三季度的 29億新元增加到 2022財年的 46億新元，增幅爲 58%。產能淨增量爲 17億新元，其中 5億新元已在 4月投產，剩餘 12億新元將從 2021年 7月開始投產。我們 2022財年收入增長預測基於產能激增。另一家工廠的產能擴張計劃將在最終確定後宣佈。#2城市發展有限公司大華繼顯維持對該公司的“買入”評級，目標股價 8.50新元。積極情緒的主要驅動力是其英國商業資產的 IPO潛力。我們瞭解到，全球第 11大主權財富基金卡塔爾投資局正尋求將其位於倫敦金絲雀碼頭（匯豐銀行總部所在地）的資產注入 CDL的英國商業房地產投資信託基金 (REIT)。我們從積極的角度看待這一發展形勢，因爲他們的舉措將壯大 REIT，引入長期投資者，併爲 REIT提供一項我們認爲具有很長加權平均租賃期的資產。由於新冠疫情影響，該 REIT的 IPO已從去年推遲到今年，目前預計會在 2021年第三季度進行。#3 P","images":[{"img":"https://static.tigerbbs.com/1dcd3b63756d8315be47f5ee71141550","width":"554","height":"369"},{"img":"https://static.tigerbbs.com/6e4a9ca6d19bbe1ff65b5eb749118357","width":"554","height":"301"},{"img":"https://static.tigerbbs.com/81783c0f1bf99cfe14d1c3aa3ecd7cce","width":"516","height":"344"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/185800004","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182719472,"gmtCreate":1623609480396,"gmtModify":1704206919540,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182719472","repostId":"182567938","repostType":1,"repost":{"id":182567938,"gmtCreate":1623590336224,"gmtModify":1704206691682,"author":{"id":"3528067440798020","authorId":"3528067440798020","name":"YOLO道","avatar":"https://static.tigerbbs.com/6e9ffc9ce8bdc6bbdf0601cfe562d658","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NIO\">$蔚來(NIO)$</a>蔚來（NYSE:NIO）最近的交易情況開始好轉了。該股在32美元反轉並穩步攀升。6月早些時候，Nio上漲超過41.45美元，然後在上週五再次突破了第二季度的高點43.22美元。多頭希望看到股價繼續守住42美元和10日移動平均線。理想情況下，之前的第二季度高點將作爲支撐。在上行方面，鑑於過去幾個月的動盪，投資者需要關注50美元這個位置。","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NIO\">$蔚來(NIO)$</a>蔚來（NYSE:NIO）最近的交易情況開始好轉了。該股在32美元反轉並穩步攀升。6月早些時候，Nio上漲超過41.45美元，然後在上週五再次突破了第二季度的高點43.22美元。多頭希望看到股價繼續守住42美元和10日移動平均線。理想情況下，之前的第二季度高點將作爲支撐。在上行方面，鑑於過去幾個月的動盪，投資者需要關注50美元這個位置。","text":"$蔚來(NIO)$蔚來（NYSE:NIO）最近的交易情況開始好轉了。該股在32美元反轉並穩步攀升。6月早些時候，Nio上漲超過41.45美元，然後在上週五再次突破了第二季度的高點43.22美元。多頭希望看到股價繼續守住42美元和10日移動平均線。理想情況下，之前的第二季度高點將作爲支撐。在上行方面，鑑於過去幾個月的動盪，投資者需要關注50美元這個位置。","images":[{"img":"https://static.tigerbbs.com/80ac0a025dad9ff4c871ee01c82b834b","width":"1046","height":"681"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182567938","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182664336,"gmtCreate":1623570009525,"gmtModify":1704206420261,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182664336","repostId":"182147050","repostType":1,"repost":{"id":182147050,"gmtCreate":1623559862466,"gmtModify":1704206196646,"author":{"id":"3527667586584720","authorId":"3527667586584720","name":"小虎综合资讯","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"真成投資李劍威：未來有更多有增長潛力的科技企業通過SPAC上市","htmlText":"6月12日，老虎證券舉辦七週年Open Day。現場多位來自一二級市場的投資大咖和業界人士，針對當前的市場行情和未來前景做出分析和預測。針對當前資本市場上最熱的上市方式之一SPAC IPO，真成投資管理合夥人李劍威向觀衆分享了對SPAC市場的觀察和對未來發展趨勢的預測。 李劍威表示，SPAC並不是剛出現市場上的新鮮事物，但從2020年下半年起，SPAC在資本市場上已經變成一種重要的融資方式，2021年第一季度有超過79%的公司選擇SPAC的方式上市。新冠疫情是SPAC走向風口的催化劑之一——疫情之後多輪刺激措施，讓市場上的流動性更加充足，散戶和和新晉股民也對於這種新的投資方式持開放態度。在風口之下，越來越多的知名人士成爲SPAC的發起人，如軟銀集團孫正義、NBA巨星奧尼爾和來自中國的李寧等。 針對爲何越來越多的公司希望通過SPAC上市，李劍威表示，“對於有上市計劃的公司而言，SPAC是一個非常有效率的通道。”傳統的IPO通常需要一年左右，需要通過很多審計師、投行、律所，定價過程也十分繁瑣，之中需要很多籌備工作。但在SPAC結構下，計劃上市企業只需要與SPAC發起人進行溝通，通常三至四個月即可完成，過程簡單且確定性高，對於標的公司來說或者計劃IPO的CEO而言，SPAC提供了更快且明確的上市路徑。東南亞的“滴滴+美團”Grab，就已宣佈通過SPAC上市。 對於投資者而言，早期參與SPAC是一個相對比較安全的方式。如果SPAC募集或沒有找到合適標的，也可進行贖回，甚至還能得到利息。SPAC的風險處在併購階段，此時估價會出現巨大波動。併購之後如何通過SPAC獲得收益，李劍威表示，“投資人要關注併購標的所處的行業賽道和商業模式，同時要關注公司的基本面。” 儘管SPAC投資火熱，但很多主流的聲音認爲SPAC是泡沫。巴菲特和芒格在今年的股東大會上指出，SPAC不僅是毒藥，還在併","listText":"6月12日，老虎證券舉辦七週年Open Day。現場多位來自一二級市場的投資大咖和業界人士，針對當前的市場行情和未來前景做出分析和預測。針對當前資本市場上最熱的上市方式之一SPAC IPO，真成投資管理合夥人李劍威向觀衆分享了對SPAC市場的觀察和對未來發展趨勢的預測。 李劍威表示，SPAC並不是剛出現市場上的新鮮事物，但從2020年下半年起，SPAC在資本市場上已經變成一種重要的融資方式，2021年第一季度有超過79%的公司選擇SPAC的方式上市。新冠疫情是SPAC走向風口的催化劑之一——疫情之後多輪刺激措施，讓市場上的流動性更加充足，散戶和和新晉股民也對於這種新的投資方式持開放態度。在風口之下，越來越多的知名人士成爲SPAC的發起人，如軟銀集團孫正義、NBA巨星奧尼爾和來自中國的李寧等。 針對爲何越來越多的公司希望通過SPAC上市，李劍威表示，“對於有上市計劃的公司而言，SPAC是一個非常有效率的通道。”傳統的IPO通常需要一年左右，需要通過很多審計師、投行、律所，定價過程也十分繁瑣，之中需要很多籌備工作。但在SPAC結構下，計劃上市企業只需要與SPAC發起人進行溝通，通常三至四個月即可完成，過程簡單且確定性高，對於標的公司來說或者計劃IPO的CEO而言，SPAC提供了更快且明確的上市路徑。東南亞的“滴滴+美團”Grab，就已宣佈通過SPAC上市。 對於投資者而言，早期參與SPAC是一個相對比較安全的方式。如果SPAC募集或沒有找到合適標的，也可進行贖回，甚至還能得到利息。SPAC的風險處在併購階段，此時估價會出現巨大波動。併購之後如何通過SPAC獲得收益，李劍威表示，“投資人要關注併購標的所處的行業賽道和商業模式，同時要關注公司的基本面。” 儘管SPAC投資火熱，但很多主流的聲音認爲SPAC是泡沫。巴菲特和芒格在今年的股東大會上指出，SPAC不僅是毒藥，還在併","text":"6月12日，老虎證券舉辦七週年Open Day。現場多位來自一二級市場的投資大咖和業界人士，針對當前的市場行情和未來前景做出分析和預測。針對當前資本市場上最熱的上市方式之一SPAC IPO，真成投資管理合夥人李劍威向觀衆分享了對SPAC市場的觀察和對未來發展趨勢的預測。 李劍威表示，SPAC並不是剛出現市場上的新鮮事物，但從2020年下半年起，SPAC在資本市場上已經變成一種重要的融資方式，2021年第一季度有超過79%的公司選擇SPAC的方式上市。新冠疫情是SPAC走向風口的催化劑之一——疫情之後多輪刺激措施，讓市場上的流動性更加充足，散戶和和新晉股民也對於這種新的投資方式持開放態度。在風口之下，越來越多的知名人士成爲SPAC的發起人，如軟銀集團孫正義、NBA巨星奧尼爾和來自中國的李寧等。 針對爲何越來越多的公司希望通過SPAC上市，李劍威表示，“對於有上市計劃的公司而言，SPAC是一個非常有效率的通道。”傳統的IPO通常需要一年左右，需要通過很多審計師、投行、律所，定價過程也十分繁瑣，之中需要很多籌備工作。但在SPAC結構下，計劃上市企業只需要與SPAC發起人進行溝通，通常三至四個月即可完成，過程簡單且確定性高，對於標的公司來說或者計劃IPO的CEO而言，SPAC提供了更快且明確的上市路徑。東南亞的“滴滴+美團”Grab，就已宣佈通過SPAC上市。 對於投資者而言，早期參與SPAC是一個相對比較安全的方式。如果SPAC募集或沒有找到合適標的，也可進行贖回，甚至還能得到利息。SPAC的風險處在併購階段，此時估價會出現巨大波動。併購之後如何通過SPAC獲得收益，李劍威表示，“投資人要關注併購標的所處的行業賽道和商業模式，同時要關注公司的基本面。” 儘管SPAC投資火熱，但很多主流的聲音認爲SPAC是泡沫。巴菲特和芒格在今年的股東大會上指出，SPAC不僅是毒藥，還在併","images":[{"img":"https://static.tigerbbs.com/90d1b38b558579b9b4683b75b131a94c","width":"1080","height":"1527"},{"img":"https://static.tigerbbs.com/1f37d5e6eb738c6f95107e5347cd67d4","width":"831","height":"234"},{"img":"https://static.tigerbbs.com/f218b1c6b04504852323978132d54018","width":"831","height":"232"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182147050","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":5,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":117,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188755059,"gmtCreate":1623463274071,"gmtModify":1704204285590,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/188755059","repostId":"1135185071","repostType":4,"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9096594378,"gmtCreate":1644417163550,"gmtModify":1676533923217,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9096594378","repostId":"1143631173","repostType":4,"isVote":1,"tweetType":1,"viewCount":710,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":388927987,"gmtCreate":1613013310749,"gmtModify":1704877379158,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/5NK.SI\">$ARTIVISION TECHNOLOGIES LTD.(5NK.SI)$</a>something wrong ...","listText":"<a href=\"https://laohu8.com/S/5NK.SI\">$ARTIVISION TECHNOLOGIES LTD.(5NK.SI)$</a>something wrong ...","text":"$ARTIVISION TECHNOLOGIES LTD.(5NK.SI)$something wrong ...","images":[{"img":"https://static.tigerbbs.com/ce064bee439726ef596ed35b29137a68","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/388927987","isVote":1,"tweetType":1,"viewCount":38,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":382359278,"gmtCreate":1613368411594,"gmtModify":1704880125430,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Give me 10 coin pls","listText":"Give me 10 coin pls","text":"Give me 10 coin pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/382359278","repostId":"2110026963","repostType":4,"repost":{"id":"2110026963","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1613109422,"share":"https://www.laohu8.com/m/news/2110026963?lang=&edition=full","pubTime":"2021-02-12 13:57","market":"us","language":"en","title":"Here's the formula for spotting genuinely undervalued companies, claims this investment house","url":"https://stock-news.laohu8.com/highlight/detail?id=2110026963","media":"Dow Jones","summary":"The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis. For most of 2020, investors poured money into names like online retailer Amazon $$, electric-car maker Tesla $$, and e-commerce platform Shopify -- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.But when news broke in early November 2020 that drug company Pfizer $$ and its partner BioNTech $$ had developed an effective vaccine against COVID-19, something pro","content":"<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's the formula for spotting genuinely undervalued companies, claims this investment house</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's the formula for spotting genuinely undervalued companies, claims this investment house\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-02-12 13:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/15e20574f8fb568333181d61bb200086","relate_stocks":{"TSLA":"特斯拉","AMZN":"亚马逊","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2110026963","content_text":"MW Here's the formula for spotting genuinely undervalued companies, claims this investment house\nThe growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis\nFor most of 2020, investors poured money into names like online retailer Amazon $(AMZN)$, electric-car maker Tesla $(TSLA)$, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.\nBut when news broke in early November 2020 that drug company Pfizer $(PFE)$ and its partner BioNTech $(BNTX)$ had developed an effective vaccine against COVID-19, something profound happened in financial markets.\nInvestors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.\nThis rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.\nAnd it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.\nThe apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.\n\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.\n\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"\nAnalysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.\nThe value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.\nIn reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.\nStocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.\nTo have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.","news_type":1},"isVote":1,"tweetType":1,"viewCount":42,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3572057948118382","authorId":"3572057948118382","name":"滚筒","avatar":"https://static.tigerbbs.com/ff35c63639130db9306c87ac66c94640","crmLevel":3,"crmLevelSwitch":0},"content":"there u go...","text":"there u go...","html":"there u go..."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803792311,"gmtCreate":1627461981533,"gmtModify":1703490424431,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/803792311","repostId":"1116394171","repostType":4,"isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":387653330,"gmtCreate":1613746374920,"gmtModify":1704884515590,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good but not for sg","listText":"Good but not for sg","text":"Good but not for sg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/387653330","repostId":"2112998868","repostType":4,"repost":{"id":"2112998868","pubTimestamp":1613654605,"share":"https://www.laohu8.com/m/news/2112998868?lang=&edition=full","pubTime":"2021-02-18 21:23","market":"us","language":"en","title":"Here's Why High Dividend Stocks Remain An Attractive Choice","url":"https://stock-news.laohu8.com/highlight/detail?id=2112998868","media":"Benzinga","summary":"According to analysts, global companies that have had a growing or stable dividend policy over the p","content":"<p><img src=\"https://static.tigerbbs.com/0d7afe1a44f30cb4b329a54a77eed026\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<p><i>According to analysts, global companies that have had a growing or stable dividend policy over the past 10 years could yield up to 5.41%, Fineco Asset Management's investment team says.</i></p>\n<p>The average yields on saving accounts across Europe are basically close to zero, while those of government bonds are mostly below 1% (for example, Italian 10-year BTPs currently yield less than 0.50%): such an environment makes investing in high dividend stocks an attractive choice.</p>\n<p><b>A Less Marked Dividend Decrease Compared To 2007-2009:</b>&nbsp;\"A valid consideration also in light of the economic crisis following the 2020 pandemic is that there was an impact on global dividends but to a lesser extent than it could be expected,\" as reported by the Fineco Asset Management Investment Team.</p>\n<p>As a matter of fact, although after the 2008 Global Financial Crisis the average dividend paid by global companies fell by 7.95% (between 2007 and 2009), the decline stopped at 3.4% between 2019 and 2020. Such divergence is due to the fact that not all market sectors were affected, and credit remained available thanks to unprecedented monetary and fiscal policy measures.</p>\n<p><b>Pepsi Co, Procter &amp; Gamble,</b>&nbsp;<b>and Johnson &amp; Johnson:</b>&nbsp;“While a number of industries - particularly those related to services, as well as non-online retail and travel industry - have suffered significantly, companies pertaining to other industries like <b>Pepsi Company Inc.</b> (NASDAQ: PEP), <b>Procter &amp; Gamble Co.</b> (NYSE: PG) and <b>Johnson &amp; Johnson</b> (NYSE: JNJ) managed to increase coupons in 2020,\"&nbsp;the team noted, adding, \"In other cases, companies like <b>Vodafone Group Plc</b> (NASDAQ: VOD) have maintained their dividend. On the other hand, the provisions imposed in the banking sector by the regulators resulted in the suspension of dividends, since it was preferred to maintain capital in banks as a precautionary measure.”</p>\n<p><b>Cautious Optimism:</b>&nbsp;Looking forward, expectations are based on cautious optimism — economies reopening and the global vaccination plan should lead to an increase in spending on services and capital goods. Such a scenario will inject confidence in the management boards, thus prompting companies to review their dividend policy.</p>\n<p><b>The Price/Earnings Ratio (P/E):</b>&nbsp;As for valuations, while stocks, in general, are not currently cheap relative to historical prices, it’s also true that high-yield dividend stocks are <a href=\"https://laohu8.com/S/AONE\">one</a> of the few areas of the stock market which are close to their historical averages.</p>\n<p>\"At the moment, the price-to-earnings (p/e) ratio of these stocks is 12.9 times the expected profits within the next 12 months, a level equal to their historical ten-year average and a much more reasonable level than the broader stock market, which trades at 18.2 times future profits against a ten-year average of 14.2. As for global growth stocks, the valuation is equal to 3.7 times 1-year sales, compared to only 1.5 times for the high-yield global stocks,” the Investment Team of Fineco Asset Management said.</p>\n<p><b>A 2% Return This Year And A 2.16% Return In 2022:</b>&nbsp;Which return will global stocks offer in 2021? After yielding an average of 1.84% in 2020, analysts expect global stocks can return 2% this year and 2.16% in 2022.</p>\n<p>\"For those global stock companies that have had a growing stable dividend for at least the last 10 years, analysts collectively expect they can yield up to 5.41% in 2021\", the investments team of Fineco Asset Management noted, considering these stocks have lagged the broader market in the past year and have not yet fully recovered from the 2020 correction.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why High Dividend Stocks Remain An Attractive Choice</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why High Dividend Stocks Remain An Attractive Choice\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-18 21:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/analyst-ratings/analyst-color/21/02/19725687/heres-why-high-dividend-stocks-remain-an-attractive-choice><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>According to analysts, global companies that have had a growing or stable dividend policy over the past 10 years could yield up to 5.41%, Fineco Asset Management's investment team says.\nThe average ...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/21/02/19725687/heres-why-high-dividend-stocks-remain-an-attractive-choice\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/87fb97aa618ed176e9a1960545651e47","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.benzinga.com/analyst-ratings/analyst-color/21/02/19725687/heres-why-high-dividend-stocks-remain-an-attractive-choice","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2112998868","content_text":"According to analysts, global companies that have had a growing or stable dividend policy over the past 10 years could yield up to 5.41%, Fineco Asset Management's investment team says.\nThe average yields on saving accounts across Europe are basically close to zero, while those of government bonds are mostly below 1% (for example, Italian 10-year BTPs currently yield less than 0.50%): such an environment makes investing in high dividend stocks an attractive choice.\nA Less Marked Dividend Decrease Compared To 2007-2009: \"A valid consideration also in light of the economic crisis following the 2020 pandemic is that there was an impact on global dividends but to a lesser extent than it could be expected,\" as reported by the Fineco Asset Management Investment Team.\nAs a matter of fact, although after the 2008 Global Financial Crisis the average dividend paid by global companies fell by 7.95% (between 2007 and 2009), the decline stopped at 3.4% between 2019 and 2020. Such divergence is due to the fact that not all market sectors were affected, and credit remained available thanks to unprecedented monetary and fiscal policy measures.\nPepsi Co, Procter & Gamble, and Johnson & Johnson: “While a number of industries - particularly those related to services, as well as non-online retail and travel industry - have suffered significantly, companies pertaining to other industries like Pepsi Company Inc. (NASDAQ: PEP), Procter & Gamble Co. (NYSE: PG) and Johnson & Johnson (NYSE: JNJ) managed to increase coupons in 2020,\" the team noted, adding, \"In other cases, companies like Vodafone Group Plc (NASDAQ: VOD) have maintained their dividend. On the other hand, the provisions imposed in the banking sector by the regulators resulted in the suspension of dividends, since it was preferred to maintain capital in banks as a precautionary measure.”\nCautious Optimism: Looking forward, expectations are based on cautious optimism — economies reopening and the global vaccination plan should lead to an increase in spending on services and capital goods. Such a scenario will inject confidence in the management boards, thus prompting companies to review their dividend policy.\nThe Price/Earnings Ratio (P/E): As for valuations, while stocks, in general, are not currently cheap relative to historical prices, it’s also true that high-yield dividend stocks are one of the few areas of the stock market which are close to their historical averages.\n\"At the moment, the price-to-earnings (p/e) ratio of these stocks is 12.9 times the expected profits within the next 12 months, a level equal to their historical ten-year average and a much more reasonable level than the broader stock market, which trades at 18.2 times future profits against a ten-year average of 14.2. As for global growth stocks, the valuation is equal to 3.7 times 1-year sales, compared to only 1.5 times for the high-yield global stocks,” the Investment Team of Fineco Asset Management said.\nA 2% Return This Year And A 2.16% Return In 2022: Which return will global stocks offer in 2021? After yielding an average of 1.84% in 2020, analysts expect global stocks can return 2% this year and 2.16% in 2022.\n\"For those global stock companies that have had a growing stable dividend for at least the last 10 years, analysts collectively expect they can yield up to 5.41% in 2021\", the investments team of Fineco Asset Management noted, considering these stocks have lagged the broader market in the past year and have not yet fully recovered from the 2020 correction.","news_type":1},"isVote":1,"tweetType":1,"viewCount":12,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":311556868,"gmtCreate":1611818590654,"gmtModify":1704863844237,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Oh noo","listText":"Oh noo","text":"Oh noo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/311556868","repostId":"1107630048","repostType":4,"repost":{"id":"1107630048","pubTimestamp":1611817916,"share":"https://www.laohu8.com/m/news/1107630048?lang=&edition=full","pubTime":"2021-01-28 15:11","market":"sg","language":"en","title":"How GameStop’s surge recalls ghosts of past trading catastrophes","url":"https://stock-news.laohu8.com/highlight/detail?id=1107630048","media":"Market Wacth","summary":"Champions of GameStop’s jaw-dropping stock surge portray it as a victory by long-suffering mom-and-p","content":"<p>Champions of GameStop’s jaw-dropping stock surge portray it as a victory by long-suffering mom-and-pop investors over nefarious Wall Street institutions, but some veteran market observers see parallels with past trading catastrophes that ultimately left those same individuals holding the bag.</p>\n<p>Richard Smith, executive director of the Foundation for the Study of Cycles, compared the run-up in shares of GameStop, along with other heavily shorted shares targeted by an army of individual investors via forums like Reddit’s WallStreetBets, to past market bubbles, albeit one that has materialized rapidly.</p>\n<p>At some point, the pool of buyers will be exhausted, he and other market observers have warned, leaving the prices of shares that have soared purely due to trading flows to potentially collapse.</p>\n<p>The obvious parallel is the dot-com bubble of the late 1990s. Like that episode, “too many businesses are making too much money off of facilitating and encouraging speculative excess by the public,” Smith said in a phone interview. “I don’t think that it’s going to end well and I’m afraid that a whole generation of investors is at risk of being lost to the capital markets.”</p>\n<p>In this case, the businesses encouraging speculative excess are online brokers and market makers, who have gamified trading and liquidity, effectively bringing Silicon Valley’s model of turning the “user into the product,” he said.</p>\n<p>GameStop Corp.GME,+134.84%sharessoared just shy of $200, or 135%, on Wednesday to end at $347.51. Shares have more than quintupled so far this week. They ended last year at $18.84. Shares of other heavily shorted companies, including theater chain AMC Entertainment Holdings Inc.AMC,+301.21%,also soared Wednesday, as Reddit users encouraged an effort to create additional short squeezes.</p>\n<p><b>Read:</b>It isn’t just GameStop: Here are some of the other heavily shorted stocks shooting higher</p>\n<p>There’s nothing new about a short squeeze, when professional investors attempt to force short sellers to buy back shares to cover losses, accelerating gains and creating a feedback loop. What’s unique this time is the way individual investors have banded together via Reddit and other forums to do battle with short sellers.</p>\n<p>The surge has been fueled by individual investors, many of whom bought out-of-the-money call options as part of a concerted effort to drive up the stock price. Market makers who sell the calls to individual investors must buy underlying shares to hedge their exposure. The sharp rally caught short sellers wrong-footed, forcing them to buy back shares at a loss, appearing to further accelerate the rally.</p>\n<p><b>See:</b>How an options-trading frenzy is lifting stocks and stirring fears of a market bubble</p>\n<p>One such short seller, Melvin Capital, was effectively KO’d earlier this week, requiring an infusion of nearly $3 billion from hedge funds Citadel and Point72 Capital. On Wednesday, Melvin Capital’s Gabe Plotkintold CNBCthat the firm’s short position was closed out the previous afternoon following a huge loss.</p>\n<p>Also, Andrew Left of short seller Citron Research,&nbsp;in a video posted to YouTube&nbsp;on Wednesday, said he covered the majority of Citron’s short position in GameStop in the $90 price range.</p>\n<p>The GameStop phenomenon, and its reliance on options-related activity by individual investors, can also be viewed as the latest chapter in a story that’s seen derivatives and supposedly sophisticated financial strategies wreak havoc in markets.</p>\n<p>In a Twitter thread, quantitative finance pioneer Emanuel Derman laid out that history, beginning with the spread of portfolio “insurance” in the 1980s, developed by finance professionals using the Black-Scholes options-pricing model. That dynamic portfolio “hedging” was blamed for amplifying the October 1987 stock-market crash.</p>\n<p>In the 2000s, credit default swaps made it easy for less-sophisticated segments of the finance profession to trade credit, contributing to the financial crisis, he said. More recently, options and futures based on the Cboe Volatility Index, or VIXVIX,+61.64%,“and the notion of volatility targeting for protection, made it easy for relative amateurs to trade volatility too, formerly also a professional skill,” he said.<img src=\"https://static.tigerbbs.com/8c3afe592d1898cadbc7abc815eecbf9\" tg-width=\"501\" tg-height=\"434\">Investors who had aggressively bet on a long stretch of market calm continuing got a rude comeuppance in February 2018, when the VIX spiked, forcing the unwind of short bets on volatility andblowing up some popular trading vehicles.</p>\n<p>“It’s all part of the trend of using derivatives that make it apparently easy to do difficult things, which, when a few people do them, isn’t too bad, but which fail when everyone does them,” Derman wrote.</p>","source":"lsy1604288433698","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How GameStop’s surge recalls ghosts of past trading catastrophes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow GameStop’s surge recalls ghosts of past trading catastrophes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-01-28 15:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/how-gamestops-surge-recalls-ghosts-of-past-trading-catastrophes-11611790728?mod=home-page><strong>Market Wacth</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Champions of GameStop’s jaw-dropping stock surge portray it as a victory by long-suffering mom-and-pop investors over nefarious Wall Street institutions, but some veteran market observers see ...</p>\n\n<a href=\"https://www.marketwatch.com/story/how-gamestops-surge-recalls-ghosts-of-past-trading-catastrophes-11611790728?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/how-gamestops-surge-recalls-ghosts-of-past-trading-catastrophes-11611790728?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107630048","content_text":"Champions of GameStop’s jaw-dropping stock surge portray it as a victory by long-suffering mom-and-pop investors over nefarious Wall Street institutions, but some veteran market observers see parallels with past trading catastrophes that ultimately left those same individuals holding the bag.\nRichard Smith, executive director of the Foundation for the Study of Cycles, compared the run-up in shares of GameStop, along with other heavily shorted shares targeted by an army of individual investors via forums like Reddit’s WallStreetBets, to past market bubbles, albeit one that has materialized rapidly.\nAt some point, the pool of buyers will be exhausted, he and other market observers have warned, leaving the prices of shares that have soared purely due to trading flows to potentially collapse.\nThe obvious parallel is the dot-com bubble of the late 1990s. Like that episode, “too many businesses are making too much money off of facilitating and encouraging speculative excess by the public,” Smith said in a phone interview. “I don’t think that it’s going to end well and I’m afraid that a whole generation of investors is at risk of being lost to the capital markets.”\nIn this case, the businesses encouraging speculative excess are online brokers and market makers, who have gamified trading and liquidity, effectively bringing Silicon Valley’s model of turning the “user into the product,” he said.\nGameStop Corp.GME,+134.84%sharessoared just shy of $200, or 135%, on Wednesday to end at $347.51. Shares have more than quintupled so far this week. They ended last year at $18.84. Shares of other heavily shorted companies, including theater chain AMC Entertainment Holdings Inc.AMC,+301.21%,also soared Wednesday, as Reddit users encouraged an effort to create additional short squeezes.\nRead:It isn’t just GameStop: Here are some of the other heavily shorted stocks shooting higher\nThere’s nothing new about a short squeeze, when professional investors attempt to force short sellers to buy back shares to cover losses, accelerating gains and creating a feedback loop. What’s unique this time is the way individual investors have banded together via Reddit and other forums to do battle with short sellers.\nThe surge has been fueled by individual investors, many of whom bought out-of-the-money call options as part of a concerted effort to drive up the stock price. Market makers who sell the calls to individual investors must buy underlying shares to hedge their exposure. The sharp rally caught short sellers wrong-footed, forcing them to buy back shares at a loss, appearing to further accelerate the rally.\nSee:How an options-trading frenzy is lifting stocks and stirring fears of a market bubble\nOne such short seller, Melvin Capital, was effectively KO’d earlier this week, requiring an infusion of nearly $3 billion from hedge funds Citadel and Point72 Capital. On Wednesday, Melvin Capital’s Gabe Plotkintold CNBCthat the firm’s short position was closed out the previous afternoon following a huge loss.\nAlso, Andrew Left of short seller Citron Research, in a video posted to YouTube on Wednesday, said he covered the majority of Citron’s short position in GameStop in the $90 price range.\nThe GameStop phenomenon, and its reliance on options-related activity by individual investors, can also be viewed as the latest chapter in a story that’s seen derivatives and supposedly sophisticated financial strategies wreak havoc in markets.\nIn a Twitter thread, quantitative finance pioneer Emanuel Derman laid out that history, beginning with the spread of portfolio “insurance” in the 1980s, developed by finance professionals using the Black-Scholes options-pricing model. That dynamic portfolio “hedging” was blamed for amplifying the October 1987 stock-market crash.\nIn the 2000s, credit default swaps made it easy for less-sophisticated segments of the finance profession to trade credit, contributing to the financial crisis, he said. More recently, options and futures based on the Cboe Volatility Index, or VIXVIX,+61.64%,“and the notion of volatility targeting for protection, made it easy for relative amateurs to trade volatility too, formerly also a professional skill,” he said.Investors who had aggressively bet on a long stretch of market calm continuing got a rude comeuppance in February 2018, when the VIX spiked, forcing the unwind of short bets on volatility andblowing up some popular trading vehicles.\n“It’s all part of the trend of using derivatives that make it apparently easy to do difficult things, which, when a few people do them, isn’t too bad, but which fail when everyone does them,” Derman wrote.","news_type":1},"isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188840267,"gmtCreate":1623429383759,"gmtModify":1704203608853,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/188840267","repostId":"1135185071","repostType":4,"isVote":1,"tweetType":1,"viewCount":111,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863037060,"gmtCreate":1632329369350,"gmtModify":1676530755294,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863037060","repostId":"886642070","repostType":1,"repost":{"id":886642070,"gmtCreate":1631589353490,"gmtModify":1676530583868,"author":{"id":"3562905647872796","authorId":"3562905647872796","name":"laochiobu","avatar":"https://static.tigerbbs.com/5b3cab7c480557b2227750c4982e4860","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>some people ask me why don't I sell it when it's at its high at $25 before it drops any lower?&nbsp;Simple. If I haven't sold it at $26 why would I sell it now? Just because the price is dropping? Never look at the current price to measure the company's future.&nbsp;","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>some people ask me why don't I sell it when it's at its high at $25 before it drops any lower?&nbsp;Simple. If I haven't sold it at $26 why would I sell it now? Just because the price is dropping? Never look at the current price to measure the company's future.&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$some people ask me why don't I sell it when it's at its high at $25 before it drops any lower? Simple. If I haven't sold it at $26 why would I sell it now? Just because the price is dropping? Never look at the current price to measure the company's future.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/886642070","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899053259,"gmtCreate":1628145103771,"gmtModify":1703502059207,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Can anyone explain, don't understand ....","listText":"Can anyone explain, don't understand ....","text":"Can anyone explain, don't understand ....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899053259","repostId":"2156164121","repostType":2,"isVote":1,"tweetType":1,"viewCount":104,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187214508,"gmtCreate":1623755269304,"gmtModify":1704210634683,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187214508","repostId":"1142697857","repostType":4,"repost":{"id":"1142697857","pubTimestamp":1623752468,"share":"https://www.laohu8.com/m/news/1142697857?lang=&edition=full","pubTime":"2021-06-15 18:21","market":"us","language":"en","title":"Fed Poised to Crawl Onto ‘Knife Edge’ to Rein In Record Largesse","url":"https://stock-news.laohu8.com/highlight/detail?id=1142697857","media":"Bloomberg","summary":"Fed wants to normalize relations with Congress, markets\nPolicy makers may begin months-long talks on","content":"<ul>\n <li>Fed wants to normalize relations with Congress, markets</li>\n <li>Policy makers may begin months-long talks on taper Tuesday</li>\n</ul>\n<p>The Federal Reserve is inching toward the start of a long road to normalizing its relationship with the rest of Washington and Wall Street.</p>\n<p>After spending the past 15 months providing unprecedented help to the federal government and investors via trillions of dollars of bond purchases, it could start preliminary discussions about scaling back that support at a pivotal two-day policy meeting that kicks off on Tuesday.</p>\n<p>Even so, actual steps in that direction by Chair Jerome Powell and his colleagues are likely still months off.</p>\n<p>Weaning Wall Street and Washington off the Fed’s extraordinary largesse won’t be easy. Since Covid-19 struck the U.S. in March 2020, the central bank has brought more than $2.5 trillion of U.S. Treasury debt, effectively covering more than half of the federal government’s red ink over that time.</p>\n<p><img src=\"https://static.tigerbbs.com/f845f5d5fa4baccad7e30207df549d71\" tg-width=\"620\" tg-height=\"348\">That buying -- together with about $870 billion in purchases of mortgage-backed securities -- has flooded the financial markets with liquidity, contributing to a doubling of the stock market from its pandemic low.</p>\n<p>“It will be like crawling along a knife-edge ridge,” former Bank of England policy maker Charles Goodhart said of the task facing the Fed. “If you do too little you’ll find inflation will just go on accelerating. If you do too much you get into a financial crisis and a recession.”</p>\n<p>Fed officials have said they want to see “substantial further progress” toward their goals of maximum employment and average 2% inflation before reducing current asset purchases of $120 billion per month. None are suggesting that they’re close to achieving that, though some have pressed for discussions to begin on a plan for tapering that buying.</p>\n<p>As Powell has pointed out more than once, payrolls are still substantially below where they were pre-pandemic -- some 7.6 million jobs short, according to the May employment report. And while inflation recently has proven surprisingly rapid -- consumer prices climbed 5% in May from a year earlier -- Powell and other Fed officials have argued that the rise is mostly transitory, the result of temporary bottlenecks as the economy reopens and low readings a year ago when it shut down.</p>\n<p><b>Price Pressures Heat Up</b></p>\n<p>U.S. core and headline inflation both increased more than forecast in May</p>\n<p><img src=\"https://static.tigerbbs.com/320b6b6419ac9bcbe999007f7786196f\" tg-width=\"643\" tg-height=\"330\">“Why would the Fed try to fix bottleneck-driven inflation by signaling earlier rate hikes and hitting demand?” Julia Coronado, president of MacroPolicy Perspectives, asked in a June 14 tweet.</p>\n<p>Instead, after years of falling short of their inflation goal, policy makers will “err on the side of patience” in scaling back stimulus, said former Fed official David Wilcox, who is now at the Peterson Institute for International Economics.</p>\n<p>Powell’s past and potential future also argue for patience. As a Fed governor in 2013, he was among those pushing then-Chairman Ben Bernanke to roll back quantitative easing, only to see the financial markets throw a “taper tantrum” at the mere suggestion such a policy shift was coming.</p>\n<p>With his own term as Fed chair up next February, Powell has an extra incentive to avoid a repeat of such turbulence.</p>\n<p>“While the Fed is an independent institution, its leadership, up for reappointment next year, could not totally ignore the dim view the administration and Democratic Congress would take toward a shift to a more pre-emptive policy stance,” Deutsche Bank chief economist David Folkerts-Landau and colleagues wrote in a June 7 report.</p>\n<p>Some three-quarters of economists surveyed by Bloomberg last week said they expect the Fed to announce between August and year-end that it will begin paring its purchases, with one-third forecasting it won’t fire the starting gun until December.</p>\n<p>It’s not just the timing of the taper that’s up for discussion. So too are its composition and pace.</p>\n<p>The Fed has faced criticism from within and outside the organization for continuing to buy $40 billion of mortgage-backed securities per month while house prices are surging. Vice Chair Randal Quarles said last month that the Fed would “certainly” look at that issue in the context of its taper discussions.</p>\n<p><b>Steady Pace</b></p>\n<p>The last time the Fed wound up a quantitative easing program, in 2014, it shrank its asset purchases at a steady pace.</p>\n<p>“Investors may be lulled into a false sense of security by that experience,” former Fed official William English told a June 8 Deutsche Bank webinar. Given all the uncertainty surrounding the post pandemic economy, “it’s not necessarily going to be the case that the Fed is going to taper in steady steps.”</p>\n<p>Much may depend on the financial markets. American Enterprise Institute resident fellow Desmond Lachman said the ultra-easy monetary policy being pursued by the Fed and other major central banks has led to an “everything asset price bubble,” with stock, credit and housing markets all frothy.</p>\n<p>“The chance of the bubble bursting is all the greater if the Fed is behind the curve,” he said.</p>\n<p>English, who is now at the Yale School of Management, said it’s going to be politically hard for the Fed to wind up its asset purchases and increase interest rates because that will boost the government’s borrowing costs.</p>\n<p>“The Fed is going to come under a lot of criticism for raising rates and making budget choices for the Congress considerably tougher,” he said, adding, “At some level, the Fed needs to both normalize policy but also normalize its relationship with the government.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed Poised to Crawl Onto ‘Knife Edge’ to Rein In Record Largesse</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed Poised to Crawl Onto ‘Knife Edge’ to Rein In Record Largesse\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 18:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-15/fed-poised-to-crawl-onto-knife-edge-to-rein-in-record-largesse><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Fed wants to normalize relations with Congress, markets\nPolicy makers may begin months-long talks on taper Tuesday\n\nThe Federal Reserve is inching toward the start of a long road to normalizing its ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-15/fed-poised-to-crawl-onto-knife-edge-to-rein-in-record-largesse\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-15/fed-poised-to-crawl-onto-knife-edge-to-rein-in-record-largesse","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142697857","content_text":"Fed wants to normalize relations with Congress, markets\nPolicy makers may begin months-long talks on taper Tuesday\n\nThe Federal Reserve is inching toward the start of a long road to normalizing its relationship with the rest of Washington and Wall Street.\nAfter spending the past 15 months providing unprecedented help to the federal government and investors via trillions of dollars of bond purchases, it could start preliminary discussions about scaling back that support at a pivotal two-day policy meeting that kicks off on Tuesday.\nEven so, actual steps in that direction by Chair Jerome Powell and his colleagues are likely still months off.\nWeaning Wall Street and Washington off the Fed’s extraordinary largesse won’t be easy. Since Covid-19 struck the U.S. in March 2020, the central bank has brought more than $2.5 trillion of U.S. Treasury debt, effectively covering more than half of the federal government’s red ink over that time.\nThat buying -- together with about $870 billion in purchases of mortgage-backed securities -- has flooded the financial markets with liquidity, contributing to a doubling of the stock market from its pandemic low.\n“It will be like crawling along a knife-edge ridge,” former Bank of England policy maker Charles Goodhart said of the task facing the Fed. “If you do too little you’ll find inflation will just go on accelerating. If you do too much you get into a financial crisis and a recession.”\nFed officials have said they want to see “substantial further progress” toward their goals of maximum employment and average 2% inflation before reducing current asset purchases of $120 billion per month. None are suggesting that they’re close to achieving that, though some have pressed for discussions to begin on a plan for tapering that buying.\nAs Powell has pointed out more than once, payrolls are still substantially below where they were pre-pandemic -- some 7.6 million jobs short, according to the May employment report. And while inflation recently has proven surprisingly rapid -- consumer prices climbed 5% in May from a year earlier -- Powell and other Fed officials have argued that the rise is mostly transitory, the result of temporary bottlenecks as the economy reopens and low readings a year ago when it shut down.\nPrice Pressures Heat Up\nU.S. core and headline inflation both increased more than forecast in May\n“Why would the Fed try to fix bottleneck-driven inflation by signaling earlier rate hikes and hitting demand?” Julia Coronado, president of MacroPolicy Perspectives, asked in a June 14 tweet.\nInstead, after years of falling short of their inflation goal, policy makers will “err on the side of patience” in scaling back stimulus, said former Fed official David Wilcox, who is now at the Peterson Institute for International Economics.\nPowell’s past and potential future also argue for patience. As a Fed governor in 2013, he was among those pushing then-Chairman Ben Bernanke to roll back quantitative easing, only to see the financial markets throw a “taper tantrum” at the mere suggestion such a policy shift was coming.\nWith his own term as Fed chair up next February, Powell has an extra incentive to avoid a repeat of such turbulence.\n“While the Fed is an independent institution, its leadership, up for reappointment next year, could not totally ignore the dim view the administration and Democratic Congress would take toward a shift to a more pre-emptive policy stance,” Deutsche Bank chief economist David Folkerts-Landau and colleagues wrote in a June 7 report.\nSome three-quarters of economists surveyed by Bloomberg last week said they expect the Fed to announce between August and year-end that it will begin paring its purchases, with one-third forecasting it won’t fire the starting gun until December.\nIt’s not just the timing of the taper that’s up for discussion. So too are its composition and pace.\nThe Fed has faced criticism from within and outside the organization for continuing to buy $40 billion of mortgage-backed securities per month while house prices are surging. Vice Chair Randal Quarles said last month that the Fed would “certainly” look at that issue in the context of its taper discussions.\nSteady Pace\nThe last time the Fed wound up a quantitative easing program, in 2014, it shrank its asset purchases at a steady pace.\n“Investors may be lulled into a false sense of security by that experience,” former Fed official William English told a June 8 Deutsche Bank webinar. Given all the uncertainty surrounding the post pandemic economy, “it’s not necessarily going to be the case that the Fed is going to taper in steady steps.”\nMuch may depend on the financial markets. American Enterprise Institute resident fellow Desmond Lachman said the ultra-easy monetary policy being pursued by the Fed and other major central banks has led to an “everything asset price bubble,” with stock, credit and housing markets all frothy.\n“The chance of the bubble bursting is all the greater if the Fed is behind the curve,” he said.\nEnglish, who is now at the Yale School of Management, said it’s going to be politically hard for the Fed to wind up its asset purchases and increase interest rates because that will boost the government’s borrowing costs.\n“The Fed is going to come under a lot of criticism for raising rates and making budget choices for the Congress considerably tougher,” he said, adding, “At some level, the Fed needs to both normalize policy but also normalize its relationship with the government.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188755059,"gmtCreate":1623463274071,"gmtModify":1704204285590,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/188755059","repostId":"1135185071","repostType":4,"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":382483316,"gmtCreate":1613475271935,"gmtModify":1704880881425,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/382483316","repostId":"1141665040","repostType":4,"repost":{"id":"1141665040","pubTimestamp":1613445230,"share":"https://www.laohu8.com/m/news/1141665040?lang=&edition=full","pubTime":"2021-02-16 11:13","market":"us","language":"en","title":"Walmart earnings, retail sales, and housing data: What to know in the week","url":"https://stock-news.laohu8.com/highlight/detail?id=1141665040","media":"Yahoo Finance","summary":"Once traders return from Monday's Presidents Day holiday, data on the strength of the U.S. consumer ","content":"<p>Once traders return from Monday's Presidents Day holiday, data on the strength of the U.S. consumer will be in focus, with the Commerce Department's monthly retail sales report and earnings results from retail giant Walmart (WMT) each on tap. A bevy of housing data is also due for release.</p><p>Consensus economists are looking for retail sales to rise by 0.9% in January over December, according to Bloomberg-compiled data. This would mark the first increase in three months after a year-end slump, and coincide with the rollout of stimulus checks to most Americans.</p><p>\"The 1.2% month-over-month rebound in retail sales we expect in January is partly due to a price-related increase in gasoline sales, but we think underlying control group and food services spending also picked up for the first time since September,\" Michael Pearce, senior U.S. economist for Capital Economics, wrote in a note Friday. \"Stimulus checks hit most Americans' bank accounts in early January, and new infection numbers fell throughout the month in most states. A rate of high-frequency indicators, including card transaction data, suggest that spending has begun to stabilize or even edge up.\"</p><p>Recent credit card transaction data from Bank of America appeared to reflect stronger purchasing trends at the beginning of the year.</p><p>\"Since the beginning of the year, total card spending is running at an average 5.6% year-over-year pace, up notably from the December average of 2.5% year-over-year,\" Bank of America economists Michelle Meyer and Anna Zhou wrote in a note last week. \"Looking at the monthly average, we find that retail sales ex-autos increased an impressive 4.6% month-over-month seasonally adjusted for January, setting up for what we expect to be a very strong Census Bureau report on February 17.\"</p><p>December's 0.7% drop in monthly retail salescame as sales at restaurants, bars, department stores and electronic stores slid further. Even sales in the category of \"non-store retailers\" — which approximates e-commerce sales — fell in December, but remained higher by more than 19% over the same month last year. And while retail sales have fallen on a month-over-month basis for the past three months, they have remained higher year-over-year to exceed pre-COVID levels since the summer.</p><p><b>Walmart earnings</b></p><p>One retailer in particular, however, has so far seen sales consistently power higher throughout much of the pandemic. Walmart's fourth-quarter results, due for release Thursday afternoon, are likely to show another surge in sales growth and profitability, as customers especially turned to big-box retailers to consolidate shopping trips during the pandemic.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c6400e641e7f6494ebb06e8de75b4332\" tg-width=\"959\" tg-height=\"640\" referrerpolicy=\"no-referrer\"><span>A worker and a shopper are seen wearing masks at a Walmart store, in North Brunswick, New Jersey, U.S. July 20, 2020. REUTERS/Eduardo Munoz</span></p><p>Same-store sales in theU.S. are expected to grow another 6.4%,matching the growth rate from the third quarter. Investors will also be looking to see whether Walmart managed to maintain momentum in e-commerce to keep pace with competitors like Amazon (AMZN) and Target (TGT). The companygrew e-commerce sales 79%in the third quarter, though this slowed from the97% rate from the prior period.Walmart's management also offered only scant details on the rollout of Walmart+, its competitor to Amazon Prime, which launched in September. And so far the company has not officially disclosed the number of paid members to the subscription service. Plus, COVID-19 costs may have continued to cut into the company's margins: Walmart reported $600 million in incremental expenses due to the virus in the third quarter, mostly due to bonuses for employees and safety measures.</p><p>Results from Walmart's fiscal fourth quarter, which spans from November through January, will also include impacts fromBlack Friday and the holiday shopping season,which took on a different format this year due to the pandemic. Walmart offered additional days of Black Friday deals on its website and in stores to mitigate some of the foot traffic to stores on the traditional shopping extravaganza, matching a similar strategy taken by peer retailers like Target around the holiday.</p><p><b>Housing data</b></p><p>The&nbsp;U.S. housing market has been one of the standout parts of the economy&nbsp;during the pandemic, with home purchases and refinances soaring against a backdrop of ultra-low interest rates.</p><p>This week's housing data is expected to reflect some moderation in this sector.</p><p>The Commerce Department's housing starts report on Thursday is expected to show that both new-home construction and permits for future construction retreated from a 14-year high. December's housing starts had surged 5.8% to a seasonally adjusted annual rate of 1.669 million, the highest level since 2006. After such a strong year-end bounce, consensus economists are looking for starts to tick down by 0.7% in January.</p><p>\"Sharp increases in single-family homes in the Midwest and South, which led the jump in housing starts in December, appear unsustainable and likely reverted partially in January. We expect a 3.6% decline in national single-family housing starts,\" Nomura economist Lewis Alexander wrote in a note. \"That said, a broad-based rise in permits for new single-family homes in December suggests the slowdown in January should be temporary.\"</p><p>Permits, which serve as a gauge of future homebuilding, are expected to drop by 2.1% after a 4.2% jump in December, which had also brought permits to the highest level since 2006.</p><p>Existing home sales, due out from the National Association of Realtors on Friday, is also expected to show a drop compared to December, as winter weather compounded with mounting affordability and supply pressures pull down buyer activity.</p><p>\"Pending home sales, contract signings that lead existing home sales (contract closings), have remained relative weak with four consecutive monthly declines starting in September,\" Alexander added. \"While remaining at an elevated level, supply shortages and affordability concerns amid rapid home price appreciation appear to be weighing on sales.\"</p><p><b>Earnings Calendar</b></p><ul><li><p><b>Monday:</b>N/A</p></li><li><p><b>Tuesday:</b>CVS (CVS), Advance Auto Parts (AAP), Palantir (PLTR) before market open; Avis Budget Group (CAR), Occidental Petroleum (OXY), Devon Energy Corporation (DVN), American International Group (AIG) after market close</p></li><li><p><b>Wednesday:</b>Hilton Worldwide (HLT), Shopify (SHOP) before market open; Boston Beer Company (SAM), Twilio (TWLO), Marathon Oil (MRO), The Cheesecake Factory (CAKE) after market close</p></li><li><p><b>Thursday:</b>Walmart (WMT), Marriott (MAR) before market open; Applied Materials (AMAT), Planet Fitness (PLNT), Dropbox (DBX), TripAdvisor (TRIP), Roku (ROKU) after market close</p></li><li><p><b>Friday:</b>Deere (DE) before market open</p></li></ul><p><b>Economic Calendar</b></p><ul><li><p><b>Monday:</b>N/A</p></li><li><p><b>Tuesday:</b>Empire Manufacturing, February (6.0 expected, 3.5 in January); Total Net TIC Flows, December ($214.1 billion in November); Net Long-Term TIC Flows, December ($149.2 billion in November)</p></li><li><p><b>Wednesday:</b>MBA Mortgage Applications, week ended February 12 (-4.1% during prior week); Producer Price Index, month-over-month, January (0.2% expected, 0.1% in December); Producer Price Index excluding food and energy, month-over-month, January (0.2% expected, 0.1% in December); Producer Price Index, year-over-year, January (0.8% expected, 0.8% in November); Producer Price Index excluding food and energy, year-over-year, January (1.1% expected, 1.2% in December); Retail Sales advance, month-over-month, January (0.9% expected, -0.7% in December); Retail Sales excluding autos and gas, month-over-month, January (0.9% expected, -1.4% in December); Industrial Production month-over-month, January (0.4% expected, 1.6% in December); Capacity Utilization, January (74.9% expected, 74.5% in December); NAHB Housing Market Index, February (83 expected, 83 in January); FOMC Meeting Minutes</p></li><li><p><b>Thursday:</b>Housing starts, January (1.650 million expected, 1.669 million in December); Building Permits, January (1.670 million expected, 1.704 million in December); Initial jobless claims, week ended February 13 (793,000 during prior week); Continuing claims, week ended Feb. 6 (4.545 million during prior week); Import Price Index, month-over-month, January (1.0% expected, 0.9% in December); Export Price Index, month-over-month, January (1.0% expected, 1.1% in December)</p></li><li><p><b>Friday:</b>Markit US Manufacturing PMI, February preliminary (58.8 expected, 59.2 in January); Markit US Composite PMI, February preliminary (58.7 in January); Markit U.S. Services PMI, February preliminary (57.8 expected, 58.3 in January); Existing home sales, January (6.55 million expected, 6.76 million in December)</p></li></ul>","source":"yahoofinance_sg","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Walmart earnings, retail sales, and housing data: What to know in the week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWalmart earnings, retail sales, and housing data: What to know in the week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-16 11:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/walmart-earnings-and-retail-sales-housing-data-what-to-know-in-the-week-ahead-165333011.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Once traders return from Monday's Presidents Day holiday, data on the strength of the U.S. consumer will be in focus, with the Commerce Department's monthly retail sales report and earnings results ...</p>\n\n<a href=\"https://finance.yahoo.com/news/walmart-earnings-and-retail-sales-housing-data-what-to-know-in-the-week-ahead-165333011.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","WMT":"沃尔玛",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/walmart-earnings-and-retail-sales-housing-data-what-to-know-in-the-week-ahead-165333011.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141665040","content_text":"Once traders return from Monday's Presidents Day holiday, data on the strength of the U.S. consumer will be in focus, with the Commerce Department's monthly retail sales report and earnings results from retail giant Walmart (WMT) each on tap. A bevy of housing data is also due for release.Consensus economists are looking for retail sales to rise by 0.9% in January over December, according to Bloomberg-compiled data. This would mark the first increase in three months after a year-end slump, and coincide with the rollout of stimulus checks to most Americans.\"The 1.2% month-over-month rebound in retail sales we expect in January is partly due to a price-related increase in gasoline sales, but we think underlying control group and food services spending also picked up for the first time since September,\" Michael Pearce, senior U.S. economist for Capital Economics, wrote in a note Friday. \"Stimulus checks hit most Americans' bank accounts in early January, and new infection numbers fell throughout the month in most states. A rate of high-frequency indicators, including card transaction data, suggest that spending has begun to stabilize or even edge up.\"Recent credit card transaction data from Bank of America appeared to reflect stronger purchasing trends at the beginning of the year.\"Since the beginning of the year, total card spending is running at an average 5.6% year-over-year pace, up notably from the December average of 2.5% year-over-year,\" Bank of America economists Michelle Meyer and Anna Zhou wrote in a note last week. \"Looking at the monthly average, we find that retail sales ex-autos increased an impressive 4.6% month-over-month seasonally adjusted for January, setting up for what we expect to be a very strong Census Bureau report on February 17.\"December's 0.7% drop in monthly retail salescame as sales at restaurants, bars, department stores and electronic stores slid further. Even sales in the category of \"non-store retailers\" — which approximates e-commerce sales — fell in December, but remained higher by more than 19% over the same month last year. And while retail sales have fallen on a month-over-month basis for the past three months, they have remained higher year-over-year to exceed pre-COVID levels since the summer.Walmart earningsOne retailer in particular, however, has so far seen sales consistently power higher throughout much of the pandemic. Walmart's fourth-quarter results, due for release Thursday afternoon, are likely to show another surge in sales growth and profitability, as customers especially turned to big-box retailers to consolidate shopping trips during the pandemic.A worker and a shopper are seen wearing masks at a Walmart store, in North Brunswick, New Jersey, U.S. July 20, 2020. REUTERS/Eduardo MunozSame-store sales in theU.S. are expected to grow another 6.4%,matching the growth rate from the third quarter. Investors will also be looking to see whether Walmart managed to maintain momentum in e-commerce to keep pace with competitors like Amazon (AMZN) and Target (TGT). The companygrew e-commerce sales 79%in the third quarter, though this slowed from the97% rate from the prior period.Walmart's management also offered only scant details on the rollout of Walmart+, its competitor to Amazon Prime, which launched in September. And so far the company has not officially disclosed the number of paid members to the subscription service. Plus, COVID-19 costs may have continued to cut into the company's margins: Walmart reported $600 million in incremental expenses due to the virus in the third quarter, mostly due to bonuses for employees and safety measures.Results from Walmart's fiscal fourth quarter, which spans from November through January, will also include impacts fromBlack Friday and the holiday shopping season,which took on a different format this year due to the pandemic. Walmart offered additional days of Black Friday deals on its website and in stores to mitigate some of the foot traffic to stores on the traditional shopping extravaganza, matching a similar strategy taken by peer retailers like Target around the holiday.Housing dataThe U.S. housing market has been one of the standout parts of the economy during the pandemic, with home purchases and refinances soaring against a backdrop of ultra-low interest rates.This week's housing data is expected to reflect some moderation in this sector.The Commerce Department's housing starts report on Thursday is expected to show that both new-home construction and permits for future construction retreated from a 14-year high. December's housing starts had surged 5.8% to a seasonally adjusted annual rate of 1.669 million, the highest level since 2006. After such a strong year-end bounce, consensus economists are looking for starts to tick down by 0.7% in January.\"Sharp increases in single-family homes in the Midwest and South, which led the jump in housing starts in December, appear unsustainable and likely reverted partially in January. We expect a 3.6% decline in national single-family housing starts,\" Nomura economist Lewis Alexander wrote in a note. \"That said, a broad-based rise in permits for new single-family homes in December suggests the slowdown in January should be temporary.\"Permits, which serve as a gauge of future homebuilding, are expected to drop by 2.1% after a 4.2% jump in December, which had also brought permits to the highest level since 2006.Existing home sales, due out from the National Association of Realtors on Friday, is also expected to show a drop compared to December, as winter weather compounded with mounting affordability and supply pressures pull down buyer activity.\"Pending home sales, contract signings that lead existing home sales (contract closings), have remained relative weak with four consecutive monthly declines starting in September,\" Alexander added. \"While remaining at an elevated level, supply shortages and affordability concerns amid rapid home price appreciation appear to be weighing on sales.\"Earnings CalendarMonday:N/ATuesday:CVS (CVS), Advance Auto Parts (AAP), Palantir (PLTR) before market open; Avis Budget Group (CAR), Occidental Petroleum (OXY), Devon Energy Corporation (DVN), American International Group (AIG) after market closeWednesday:Hilton Worldwide (HLT), Shopify (SHOP) before market open; Boston Beer Company (SAM), Twilio (TWLO), Marathon Oil (MRO), The Cheesecake Factory (CAKE) after market closeThursday:Walmart (WMT), Marriott (MAR) before market open; Applied Materials (AMAT), Planet Fitness (PLNT), Dropbox (DBX), TripAdvisor (TRIP), Roku (ROKU) after market closeFriday:Deere (DE) before market openEconomic CalendarMonday:N/ATuesday:Empire Manufacturing, February (6.0 expected, 3.5 in January); Total Net TIC Flows, December ($214.1 billion in November); Net Long-Term TIC Flows, December ($149.2 billion in November)Wednesday:MBA Mortgage Applications, week ended February 12 (-4.1% during prior week); Producer Price Index, month-over-month, January (0.2% expected, 0.1% in December); Producer Price Index excluding food and energy, month-over-month, January (0.2% expected, 0.1% in December); Producer Price Index, year-over-year, January (0.8% expected, 0.8% in November); Producer Price Index excluding food and energy, year-over-year, January (1.1% expected, 1.2% in December); Retail Sales advance, month-over-month, January (0.9% expected, -0.7% in December); Retail Sales excluding autos and gas, month-over-month, January (0.9% expected, -1.4% in December); Industrial Production month-over-month, January (0.4% expected, 1.6% in December); Capacity Utilization, January (74.9% expected, 74.5% in December); NAHB Housing Market Index, February (83 expected, 83 in January); FOMC Meeting MinutesThursday:Housing starts, January (1.650 million expected, 1.669 million in December); Building Permits, January (1.670 million expected, 1.704 million in December); Initial jobless claims, week ended February 13 (793,000 during prior week); Continuing claims, week ended Feb. 6 (4.545 million during prior week); Import Price Index, month-over-month, January (1.0% expected, 0.9% in December); Export Price Index, month-over-month, January (1.0% expected, 1.1% in December)Friday:Markit US Manufacturing PMI, February preliminary (58.8 expected, 59.2 in January); Markit US Composite PMI, February preliminary (58.7 in January); Markit U.S. Services PMI, February preliminary (57.8 expected, 58.3 in January); Existing home sales, January (6.55 million expected, 6.76 million in December)","news_type":1},"isVote":1,"tweetType":1,"viewCount":74,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":382034596,"gmtCreate":1613298640215,"gmtModify":1704879809879,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/382034596","repostId":"2110026963","repostType":4,"repost":{"id":"2110026963","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1613109422,"share":"https://www.laohu8.com/m/news/2110026963?lang=&edition=full","pubTime":"2021-02-12 13:57","market":"us","language":"en","title":"Here's the formula for spotting genuinely undervalued companies, claims this investment house","url":"https://stock-news.laohu8.com/highlight/detail?id=2110026963","media":"Dow Jones","summary":"The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis. For most of 2020, investors poured money into names like online retailer Amazon $$, electric-car maker Tesla $$, and e-commerce platform Shopify -- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.But when news broke in early November 2020 that drug company Pfizer $$ and its partner BioNTech $$ had developed an effective vaccine against COVID-19, something pro","content":"<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's the formula for spotting genuinely undervalued companies, claims this investment house</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's the formula for spotting genuinely undervalued companies, claims this investment house\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-02-12 13:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/15e20574f8fb568333181d61bb200086","relate_stocks":{"TSLA":"特斯拉","AMZN":"亚马逊","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2110026963","content_text":"MW Here's the formula for spotting genuinely undervalued companies, claims this investment house\nThe growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis\nFor most of 2020, investors poured money into names like online retailer Amazon $(AMZN)$, electric-car maker Tesla $(TSLA)$, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.\nBut when news broke in early November 2020 that drug company Pfizer $(PFE)$ and its partner BioNTech $(BNTX)$ had developed an effective vaccine against COVID-19, something profound happened in financial markets.\nInvestors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.\nThis rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.\nAnd it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.\nThe apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.\n\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.\n\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"\nAnalysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.\nThe value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.\nIn reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.\nStocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.\nTo have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.","news_type":1},"isVote":1,"tweetType":1,"viewCount":19,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":310829442,"gmtCreate":1611308819886,"gmtModify":1704859461906,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good ari stock","listText":"Good ari stock","text":"Good ari stock","images":[{"img":"https://static.tigerbbs.com/f7291658e2aac6cf53101760dfeb4d7b","width":"1080","height":"2370"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/310829442","isVote":1,"tweetType":1,"viewCount":37,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0},"content":"Finally, when you first post [compare heart] [compare heart] post, you can get more exposure by related stocks or related topics. If you want to create high-quality articles, please checkGuidelines for Tiger Community Creation","text":"Finally, when you first post [compare heart] [compare heart] post, you can get more exposure by related stocks or related topics. If you want to create high-quality articles, please checkGuidelines for Tiger Community Creation","html":"Finally, when you first post [compare heart] [compare heart] post, you can get more exposure by related stocks or related topics. If you want to create high-quality articles, please checkGuidelines for Tiger Community Creation"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9002902307,"gmtCreate":1641874722247,"gmtModify":1676533658096,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good !","listText":"Good !","text":"Good !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002902307","repostId":"1104925214","repostType":2,"repost":{"id":"1104925214","pubTimestamp":1641868694,"share":"https://www.laohu8.com/m/news/1104925214?lang=&edition=full","pubTime":"2022-01-11 10:38","market":"us","language":"en","title":"7 Hot Stocks to Buy on Any Dip This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1104925214","media":"InvestorPlace","summary":"An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock v","content":"<html><head></head><body><p>An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock valuations and now the super-contagious omicron variant of Covid-19. As a result, forecasting market performance for 2022 seems more difficult than it’s been in previous years. Right now, it looks like the market is priced to perfection with a slim margin of error. Therefore, investors could benefit by keeping an eye on hot stocks.</p><p>Since March 2020, the bull market has seen returns of nearly 110% in the <b>S&amp;P 500</b>Index. Despite such a remarkable rally, we need to highlight that 93% of the index saw a selloff of more than 10% in 2021.</p><p>While Wells Fargo predicts that the S&amp;P 500 index could hit 5,300, Morgan Stanley has a bearish outlook with a year-end 2022 target for 4,400. That suggest a decline of more than 4% from current levels.</p><p>Amidst so much uncertainty, market analysts have expressed conflicting opinions about where investor gains in the new year may come from. Market forecasts for 2022 might ultimately rely on correctly forecasting how the pandemic evolves. “The pathof the economy continues to depend on the course of the virus,” the Federal Open Market Committee’s stated following the Federal Reserve meeting in December.</p><p>With that information, here are seven hot stocks that offer substantial upside to any investor portfolio in 2022:</p><ul><li><b>Analog Devices</b>(NASDAQ:<b>ADI</b>)</li><li><b>Applied Materials</b>(NASDAQ:<b>AMAT</b>)</li><li><b>Charles Schwab</b>(NYSE:<b>SCHW</b>)</li><li><b>Dupont De Nemours</b> (NYSE:<b>DD</b>)</li><li><b>Fisker</b> (NYSE:<b>FSR</b>)</li><li><b>Unity Software</b>(NYSE:<b>U</b>)</li><li><b>USCF Midstream Energy Income Fund</b>(NYSEARCA:<b>UMI</b>)</li></ul><p><b>Hot Stocks: Analog Devices</b>(ADI)</p><p><b>52-week range:</b>$142.25 – $191.95</p><p><b>Dividend yield:</b>1.6%</p><p>Leading our list of hot stocks to watch is Wilmington, Massachusetts-based Analog Devices. The company manufactures chips that leverage high-performance analog, mixed-signal and digital signal processing technology. The chipmaker has a leading market share in converter chips that translate analog signals to digital and vice versa.</p><p>Analog Devices announced fourth-quarter 2021 results on Nov. 23, 2021. Revenue increased 53% year-over-year (YOY) to $2.34 billion. Adjusted earnings increased from $1.44 per share to $1.73 per share. The chipmaker generated a free cash flow of $810 million during the period. Cash and equivalents ended the quarter at $1.98 billion.</p><p>On the metrics, CEO Vincent Roche said, “ADI delivered another quarter of record revenue and profits, marking a strong end to the fiscal year. Our Industrial and Automotive markets reached all-time highs and our Consumer business returned to solid growth in fiscal 2021.”</p><p>The chipmaker continues to expand its manufacturing capacity to meet the rising demand for its cutting-edge chips. In fact, Analog received more orders than it could fill during the past year, leading to a solid backlog for its products. Moreover, it has recently completed the acquisition of Maxim Integrated, further solidifying its position as a semiconductor leader.</p><p>Most of Analog’s revenue comes from the industrial and automotive markets. Factory automation is driving surging demand for sensors and connectivity options for machines, all of which require the use of ADI’s chips. Furthermore, the automotive industry’s demand for chips continues to grow rapidly due to the increasing popularity of electric vehicles(EVs).</p><p>Currently, ADI stock hovers just below $170 per share, up nearly 8% over the past 12 months. Shares are trading at 24 times forward earnings and 10 times trailing sales. The 12-month median price forecast for Analog Devicesstands at $210.</p><p><b>Applied Materials</b>(AMAT)</p><p><b>52-week range:</b>$94.18 – $163.02</p><p><b>Dividend yield:</b>0.6%</p><p>When it comes to semiconductor manufacturing equipment, the one company that tops the list is the Santa Clara, California-based Applied Materials. It iswell-known for materials and engineering solutions.</p><p>Applied Materials released Q4 2021 results in mid-November. It reported a record quarterly revenue of $6.12 billion, up 31% YOY. Adjusted net income came in at $1.76 billion, or $1.94 per diluted share, up 53% YOY from $1.15 billion, or $1.25 per diluted share, in the prior-year quarter.</p><p>“Applied delivered strong growth in fiscal 2021, with overall orders up by 62 percent year over year and Semiconductor Systems orders up 78 percent,” remarked CFO Bob Halliday. “The momentum continued as our Semiconductor Systems backlog increased during the fourth quarter from $5.5 billion to $6.7 billion, and we see this strength sustaining into 2022.”</p><p>The company stands to benefit from crucial high-growth trends, including artificial intelligence, 5G, cloud computing, the Internet of Things (IoT) and autonomous driving. In particular, Applied Materials continues to gain significant market share in process control, including wafer inspection and e-beam technology. Demand for these services should keep AMAT on your list of hot stocks to watch.</p><p>In addition, Applied Materials plays a vital role in the U.S. tech industry. The lion’s share of global chip manufacturing is based in Taiwan, so the U.S. and Europe are looking to expand their domestic chip manufacturing capabilities. This implies significant long-term growth opportunities for equipment suppliers like Applied Materials.</p><p>At present, AMAT stock is priced around $145. Over the past 12 months, it has surged 53%. Given the rising global demand for foundry and logic capacity, the company has a moderate valuation at 18.7 times forward earnings and 6.1 times trailing sales. The 12-month median price forecast for Applied Materials stock stands at $174.</p><p><b>Hot Stocks: Charles Schwab</b>(SCHW)</p><p><b>52-week range:</b>$50.77 – $92.32</p><p><b>Dividend yield:</b>0.8%</p><p>In addition to brokerage services, the San Francisco, California-based Charles Schwab offers asset management, wealth management, banking, and other financial advisory services. Currently,the group boasts about $8 trillion in client assets, nearly 33 million active brokerage accounts and more than 2 million corporate retirement plan participants.</p><p>Charles Schwab released Q3 2021 results in mid-October. Revenue surged 87% YOY to $4.57 billion. Further, adjusted net income grew 130% to $1.72 billion, or 84 cents per diluted share, up from $749 million, or 51 cents per diluted share, a year ago.</p><p>On the results, CEO Walt Bettinger remarked, “We generated core net new assets of $139.0 billion in the quarter, pushing asset gathering for the first nine months of the year to $396.0 billion, representing an 8% annualized organic growth rate. Total client assets ended September at $7.61 trillion, up from $6.69 trillion at year-end 2020.”</p><p>In 2021, the increase in assets contributed to high growth. Now Wall Street concurs that Schwab should benefit from rising interest rates in 2022. Net interest revenue accounted for around 45% of total revenue in Q3.</p><p>Considering the anticipated increase in interest rates and Schwab’s powerful organic growth potential, many investors are following SCHW stock closely. It currently hovers in $90 territory, and over the past 12 months, the stock price has jumped 54%. SCHW is trading at 23.3 times forward earnings and 8.5 times trailing sales. The 12-month median price forecast for Charles Schwab stock stands at $95.50.</p><p><b>Dupont De Nemours</b> (DD)</p><p><b>52-week range:</b>$66.37 – $87.27</p><p><b>Dividend yield:</b>1.44%</p><p>DuPont de Nemours is one of the largest chemical and specialty materials companies worldwide. It provides many synthetic components that serve automotive, electronics, construction, safety and water management industries.</p><p>The company released Q3 2021 results in early November. Revenue for the period totaled $4.3 billion, up 18% YOY. Net income stood at $391 million, or 75 cents per diluted share, compared to a net loss of $79 million, or a loss of 11 cents loss per diluted share, in the prior-year quarter. Dupont generated a free cash flow of $634 million during the quarter. Cash and equivalents ended the quarter at $1.67 billion.</p><p>DuPont is going through a transition period, shifting its focus from low-margin chemical businesses to higher-margin opportunities in sectors with long-term growth potential. In November, management announced the acquisitionof<b>Rogers Corporation</b> for $5.2 billion.</p><p>This acquisition allows DuPont to gain exposure to secular high-growth markets, including electric vehicles, 5G and clean energy. Meanwhile, DuPont plans to divest most of its Mobility &amp; Materials segment, including engineering polymers and performance resins products lines.</p><p>On the acquisition, CEO Ed Breen remarked, “Today we also separately announced a definitive agreement to acquire Rogers Corporation, an advanced materials provider with superior technology innovation, applications engineering expertise, and leading end-market positions.”</p><p>DD stock is currently priced just below $82 per share, up 2% in the past 12 months. Shares are trading at 16.5 times forward earnings and 2.2 times trailing sales. The 12-month median price forecast for DuPont stock stands at $96.</p><p><b>Hot Stocks: Fisker</b> (FSR)</p><p><b>52-week range:</b>$9.61 – $31.96</p><p>Manhattan Beach, California-based Fisker is a pre-revenue EV name that made its market debut in 2020. It has a unique asset-light business model based on contract manufacturing.</p><p>Fisker released Q3 2021 results in early November. Net loss for the period totaled $110 million, or a loss of 37 cents per share, compared to a net loss of $40 million in the previous year. Cash and equivalents ended the quarter at $1.4 billion.</p><p>After the announcement, CEO Henrik Fisker noted, “We continued to make rapid progress in Q3 2021 on our core focus, achieving program milestones that ensure we execute Fisker Ocean SUV on-time and with several segment-leading features.”</p><p>Production for the Fisker Ocean, a mid-size premium SUV, is set to begin in November. The EV will be available to consumers through a leasing package that costs $37,499, making it one of the most affordable EVs on the market. Fisker Ocean reservations are expected to increase in 2022 with the opening of experience centers.</p><p>The Ocean is sold exclusively through the Fisker app or website without a dealer network. As a result, Wall Street is interested in its low overhead costs. Further, contract manufacturing should allow the company to enhance its EV portfolio without investing in risky manufacturing capacity.</p><p>Understandably, without revenues, Fisker is a speculative EV play. FSR stock hovers in $15 territory, up 2% over the past year. The 12-month median price forecast for Fisker stock stands at $25.50.</p><p><b>Unity Software</b>(U)</p><p><b>52-week range:</b>$76 – $210</p><p>Unity Software offers a software platform for developing interactive experiences and creating computer-generated visuals. The company is well-known for providing an engine for video games that work across computers, consoles, smart phones and virtual reality (VR) devices.</p><p>Unity reported Q3 2021 results in early November. Revenue soared 43% YOY to $286 million. But non-GAAP loss widened to $12.1 million, or 6 cents per diluted share, compared to a loss of $8.4 million, or 9 cents per diluted share, in the previous year. Cash and equivalents ended the period at $755 million.</p><p>On the results, CEO John Riccitiello remarked, “Unity’s strong performance this quarter was driven by innovation in data science, vertical growth and making significant strides in bringing RT3D technologies and tools to as many creators and artists as possible.”</p><p>Wall Street agrees Unity should benefit from the development of the metaverse. It is swiftly gaining a solid foothold in the VR and augmented reality (AR) markets. Around 60% of all games built for AR and VR are currently utilizing its engine services.</p><p>Moreover, Unity has recently acquired the visual-effects studioWeta Digital. This new business could soon enable the company to offer digital-effects services for film, games and television.</p><p>Unity hit an all-time high of $210 in mid-November. However, it currently trades around $125, down 13% over the past year. Shares are trading at 39x trailing sales. The 12-month median price forecast for Unity stock stands at $185.</p><p><b>Hot Stocks: USCF Midstream Energy Income Fund</b>(UMI)</p><p><b>52-Week Range:</b> $24.32 – $32.62</p><p><b>Expense Ratio:</b> 0.85% per year</p><p>Closing out this list of hot stocks to monitor is the USCF Midstream Energy Income Fund, an exchange-traded fund (ETF).It invests in U.S. and Canadian midstream energy companies, including master limited partnerships (MLPs). These energy infrastructure companies focus on transportation, storage, gathering and processing of energy.</p><p>UMI, which started trading in March 2021, has24 holdings. Fund managers choose companies based on their income growth, balance sheet strength, distribution (or dividend) coverage and contract quality. Exposure to commodity prices is also important as it can impact share prices, especially in the short run.</p><p>The top 10 names account for around 65% of net assets of $125.2 million. Among the leading names on the roster are <b>Targa Resources</b>(NYSE:<b><u>TRGP</u></b>),<b>Enbridge</b>(NYSE:<b><u>ENB</u></b>) and <b>Enterprise Products Partners</b>(NYSE:<b><u>EPD</u></b>).</p><p>Robust MLPs with quality contracts and solid fundamental metrics tend to be cash cows that most investors love. Since its inception in March 2020, UMI has soared more than 20% and saw a record high of $32.62 in mid-October. Interested investors should consider buying at $28.50.</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Hot Stocks to Buy on Any Dip This Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Hot Stocks to Buy on Any Dip This Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-11 10:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/01/7-hot-stocks-to-buy-on-any-dip-this-year/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock valuations and now the super-contagious omicron variant of Covid-19. As a result, forecasting market ...</p>\n\n<a href=\"https://investorplace.com/2022/01/7-hot-stocks-to-buy-on-any-dip-this-year/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FSR":"菲斯克","U":"Unity Software Inc.","DD":"杜邦","ADI":"亚德诺","UMI":"USCF Midstream Energy Income Fund","SCHW":"嘉信理财","ADMT":"ADM Tronics Unlimited, Inc."},"source_url":"https://investorplace.com/2022/01/7-hot-stocks-to-buy-on-any-dip-this-year/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104925214","content_text":"An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock valuations and now the super-contagious omicron variant of Covid-19. As a result, forecasting market performance for 2022 seems more difficult than it’s been in previous years. Right now, it looks like the market is priced to perfection with a slim margin of error. Therefore, investors could benefit by keeping an eye on hot stocks.Since March 2020, the bull market has seen returns of nearly 110% in the S&P 500Index. Despite such a remarkable rally, we need to highlight that 93% of the index saw a selloff of more than 10% in 2021.While Wells Fargo predicts that the S&P 500 index could hit 5,300, Morgan Stanley has a bearish outlook with a year-end 2022 target for 4,400. That suggest a decline of more than 4% from current levels.Amidst so much uncertainty, market analysts have expressed conflicting opinions about where investor gains in the new year may come from. Market forecasts for 2022 might ultimately rely on correctly forecasting how the pandemic evolves. “The pathof the economy continues to depend on the course of the virus,” the Federal Open Market Committee’s stated following the Federal Reserve meeting in December.With that information, here are seven hot stocks that offer substantial upside to any investor portfolio in 2022:Analog Devices(NASDAQ:ADI)Applied Materials(NASDAQ:AMAT)Charles Schwab(NYSE:SCHW)Dupont De Nemours (NYSE:DD)Fisker (NYSE:FSR)Unity Software(NYSE:U)USCF Midstream Energy Income Fund(NYSEARCA:UMI)Hot Stocks: Analog Devices(ADI)52-week range:$142.25 – $191.95Dividend yield:1.6%Leading our list of hot stocks to watch is Wilmington, Massachusetts-based Analog Devices. The company manufactures chips that leverage high-performance analog, mixed-signal and digital signal processing technology. The chipmaker has a leading market share in converter chips that translate analog signals to digital and vice versa.Analog Devices announced fourth-quarter 2021 results on Nov. 23, 2021. Revenue increased 53% year-over-year (YOY) to $2.34 billion. Adjusted earnings increased from $1.44 per share to $1.73 per share. The chipmaker generated a free cash flow of $810 million during the period. Cash and equivalents ended the quarter at $1.98 billion.On the metrics, CEO Vincent Roche said, “ADI delivered another quarter of record revenue and profits, marking a strong end to the fiscal year. Our Industrial and Automotive markets reached all-time highs and our Consumer business returned to solid growth in fiscal 2021.”The chipmaker continues to expand its manufacturing capacity to meet the rising demand for its cutting-edge chips. In fact, Analog received more orders than it could fill during the past year, leading to a solid backlog for its products. Moreover, it has recently completed the acquisition of Maxim Integrated, further solidifying its position as a semiconductor leader.Most of Analog’s revenue comes from the industrial and automotive markets. Factory automation is driving surging demand for sensors and connectivity options for machines, all of which require the use of ADI’s chips. Furthermore, the automotive industry’s demand for chips continues to grow rapidly due to the increasing popularity of electric vehicles(EVs).Currently, ADI stock hovers just below $170 per share, up nearly 8% over the past 12 months. Shares are trading at 24 times forward earnings and 10 times trailing sales. The 12-month median price forecast for Analog Devicesstands at $210.Applied Materials(AMAT)52-week range:$94.18 – $163.02Dividend yield:0.6%When it comes to semiconductor manufacturing equipment, the one company that tops the list is the Santa Clara, California-based Applied Materials. It iswell-known for materials and engineering solutions.Applied Materials released Q4 2021 results in mid-November. It reported a record quarterly revenue of $6.12 billion, up 31% YOY. Adjusted net income came in at $1.76 billion, or $1.94 per diluted share, up 53% YOY from $1.15 billion, or $1.25 per diluted share, in the prior-year quarter.“Applied delivered strong growth in fiscal 2021, with overall orders up by 62 percent year over year and Semiconductor Systems orders up 78 percent,” remarked CFO Bob Halliday. “The momentum continued as our Semiconductor Systems backlog increased during the fourth quarter from $5.5 billion to $6.7 billion, and we see this strength sustaining into 2022.”The company stands to benefit from crucial high-growth trends, including artificial intelligence, 5G, cloud computing, the Internet of Things (IoT) and autonomous driving. In particular, Applied Materials continues to gain significant market share in process control, including wafer inspection and e-beam technology. Demand for these services should keep AMAT on your list of hot stocks to watch.In addition, Applied Materials plays a vital role in the U.S. tech industry. The lion’s share of global chip manufacturing is based in Taiwan, so the U.S. and Europe are looking to expand their domestic chip manufacturing capabilities. This implies significant long-term growth opportunities for equipment suppliers like Applied Materials.At present, AMAT stock is priced around $145. Over the past 12 months, it has surged 53%. Given the rising global demand for foundry and logic capacity, the company has a moderate valuation at 18.7 times forward earnings and 6.1 times trailing sales. The 12-month median price forecast for Applied Materials stock stands at $174.Hot Stocks: Charles Schwab(SCHW)52-week range:$50.77 – $92.32Dividend yield:0.8%In addition to brokerage services, the San Francisco, California-based Charles Schwab offers asset management, wealth management, banking, and other financial advisory services. Currently,the group boasts about $8 trillion in client assets, nearly 33 million active brokerage accounts and more than 2 million corporate retirement plan participants.Charles Schwab released Q3 2021 results in mid-October. Revenue surged 87% YOY to $4.57 billion. Further, adjusted net income grew 130% to $1.72 billion, or 84 cents per diluted share, up from $749 million, or 51 cents per diluted share, a year ago.On the results, CEO Walt Bettinger remarked, “We generated core net new assets of $139.0 billion in the quarter, pushing asset gathering for the first nine months of the year to $396.0 billion, representing an 8% annualized organic growth rate. Total client assets ended September at $7.61 trillion, up from $6.69 trillion at year-end 2020.”In 2021, the increase in assets contributed to high growth. Now Wall Street concurs that Schwab should benefit from rising interest rates in 2022. Net interest revenue accounted for around 45% of total revenue in Q3.Considering the anticipated increase in interest rates and Schwab’s powerful organic growth potential, many investors are following SCHW stock closely. It currently hovers in $90 territory, and over the past 12 months, the stock price has jumped 54%. SCHW is trading at 23.3 times forward earnings and 8.5 times trailing sales. The 12-month median price forecast for Charles Schwab stock stands at $95.50.Dupont De Nemours (DD)52-week range:$66.37 – $87.27Dividend yield:1.44%DuPont de Nemours is one of the largest chemical and specialty materials companies worldwide. It provides many synthetic components that serve automotive, electronics, construction, safety and water management industries.The company released Q3 2021 results in early November. Revenue for the period totaled $4.3 billion, up 18% YOY. Net income stood at $391 million, or 75 cents per diluted share, compared to a net loss of $79 million, or a loss of 11 cents loss per diluted share, in the prior-year quarter. Dupont generated a free cash flow of $634 million during the quarter. Cash and equivalents ended the quarter at $1.67 billion.DuPont is going through a transition period, shifting its focus from low-margin chemical businesses to higher-margin opportunities in sectors with long-term growth potential. In November, management announced the acquisitionofRogers Corporation for $5.2 billion.This acquisition allows DuPont to gain exposure to secular high-growth markets, including electric vehicles, 5G and clean energy. Meanwhile, DuPont plans to divest most of its Mobility & Materials segment, including engineering polymers and performance resins products lines.On the acquisition, CEO Ed Breen remarked, “Today we also separately announced a definitive agreement to acquire Rogers Corporation, an advanced materials provider with superior technology innovation, applications engineering expertise, and leading end-market positions.”DD stock is currently priced just below $82 per share, up 2% in the past 12 months. Shares are trading at 16.5 times forward earnings and 2.2 times trailing sales. The 12-month median price forecast for DuPont stock stands at $96.Hot Stocks: Fisker (FSR)52-week range:$9.61 – $31.96Manhattan Beach, California-based Fisker is a pre-revenue EV name that made its market debut in 2020. It has a unique asset-light business model based on contract manufacturing.Fisker released Q3 2021 results in early November. Net loss for the period totaled $110 million, or a loss of 37 cents per share, compared to a net loss of $40 million in the previous year. Cash and equivalents ended the quarter at $1.4 billion.After the announcement, CEO Henrik Fisker noted, “We continued to make rapid progress in Q3 2021 on our core focus, achieving program milestones that ensure we execute Fisker Ocean SUV on-time and with several segment-leading features.”Production for the Fisker Ocean, a mid-size premium SUV, is set to begin in November. The EV will be available to consumers through a leasing package that costs $37,499, making it one of the most affordable EVs on the market. Fisker Ocean reservations are expected to increase in 2022 with the opening of experience centers.The Ocean is sold exclusively through the Fisker app or website without a dealer network. As a result, Wall Street is interested in its low overhead costs. Further, contract manufacturing should allow the company to enhance its EV portfolio without investing in risky manufacturing capacity.Understandably, without revenues, Fisker is a speculative EV play. FSR stock hovers in $15 territory, up 2% over the past year. The 12-month median price forecast for Fisker stock stands at $25.50.Unity Software(U)52-week range:$76 – $210Unity Software offers a software platform for developing interactive experiences and creating computer-generated visuals. The company is well-known for providing an engine for video games that work across computers, consoles, smart phones and virtual reality (VR) devices.Unity reported Q3 2021 results in early November. Revenue soared 43% YOY to $286 million. But non-GAAP loss widened to $12.1 million, or 6 cents per diluted share, compared to a loss of $8.4 million, or 9 cents per diluted share, in the previous year. Cash and equivalents ended the period at $755 million.On the results, CEO John Riccitiello remarked, “Unity’s strong performance this quarter was driven by innovation in data science, vertical growth and making significant strides in bringing RT3D technologies and tools to as many creators and artists as possible.”Wall Street agrees Unity should benefit from the development of the metaverse. It is swiftly gaining a solid foothold in the VR and augmented reality (AR) markets. Around 60% of all games built for AR and VR are currently utilizing its engine services.Moreover, Unity has recently acquired the visual-effects studioWeta Digital. This new business could soon enable the company to offer digital-effects services for film, games and television.Unity hit an all-time high of $210 in mid-November. However, it currently trades around $125, down 13% over the past year. Shares are trading at 39x trailing sales. The 12-month median price forecast for Unity stock stands at $185.Hot Stocks: USCF Midstream Energy Income Fund(UMI)52-Week Range: $24.32 – $32.62Expense Ratio: 0.85% per yearClosing out this list of hot stocks to monitor is the USCF Midstream Energy Income Fund, an exchange-traded fund (ETF).It invests in U.S. and Canadian midstream energy companies, including master limited partnerships (MLPs). These energy infrastructure companies focus on transportation, storage, gathering and processing of energy.UMI, which started trading in March 2021, has24 holdings. Fund managers choose companies based on their income growth, balance sheet strength, distribution (or dividend) coverage and contract quality. Exposure to commodity prices is also important as it can impact share prices, especially in the short run.The top 10 names account for around 65% of net assets of $125.2 million. Among the leading names on the roster are Targa Resources(NYSE:TRGP),Enbridge(NYSE:ENB) and Enterprise Products Partners(NYSE:EPD).Robust MLPs with quality contracts and solid fundamental metrics tend to be cash cows that most investors love. Since its inception in March 2020, UMI has soared more than 20% and saw a record high of $32.62 in mid-October. Interested investors should consider buying at $28.50.","news_type":1},"isVote":1,"tweetType":1,"viewCount":709,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816818466,"gmtCreate":1630486262755,"gmtModify":1676530316959,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/816818466","repostId":"813432346","repostType":1,"repost":{"id":813432346,"gmtCreate":1630227789685,"gmtModify":1676530247507,"author":{"id":"3561958952819268","authorId":"3561958952819268","name":"ARK女神","avatar":"https://static.tigerbbs.com/3f4dec49acccdeef585e67230709521a","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"title":"財報應該看什麼？教你幾招掌握閱讀財報的技巧","htmlText":"投資者爲什麼一定要會看財報？直接出錢投資不就好了嗎？如果你也抱着同樣的想法，對每個季度發佈的季報和每年發佈的年報視若無睹的話，你可能虧了錢都不知道爲什麼錢會沒了。財報，顯示了公司的財務和經營狀況。你不認識公司的CEO或管理層沒關係，至少你要學會通過分析財報來了解公司當下的發展狀況和成長空間，才能決定是否投資、投資更多，或者是及早離場。但是，密密麻麻的文字和數字，應該看什麼、怎麼看？今天，教你幾招掌握閱讀財報的技巧。上市公司必須按季度定期披露公司的經營情況，所以就有第一季度、第二季度（中期報告）、第三季度和第四季度。通常在公佈第四季度的同時，也會總結一整年的統計數據。從內容來看，季報會比較簡單，多數都會包含資產負債表、損益表和現金流量表三大報表。但是，有些公司會選擇不披露現金流量數據，這也很正常。年報是總結了一整年業績後所呈現給股東的報告。年報是經過會計師事務所審計過的，季報裏任何誤差會在年報裏糾正，所以可信程度上是最高的，提供的資料信息也是最全面的。【財報的時間】首先，大家必須知道每家公司的財政年度未必都是1月至12月。因此，要知道公司什麼時候會公佈季報或年報，投資者就得先了解公司的財政年度。舉個例子，如果公司的財政年度是2月至隔年1月，公司第一季度的財報涵蓋的就是2月至4月的業績報告，以此類推。每個季度結束後，公司有多少時間準備財報呢？每個國家的證監會給予上市公司遞交財報的時限略有不同，多數介於1-3個月之間。以美股爲例，美國證監會要求上市3年以上的公司，必須在每個季度結束後的35天之內遞交季度財報，在財政年度結束後的60天內遞交年報。【財報看點】1. 主席致辭 (Chairman’s Statement)「主席致辭」是年報裏應該重點閱讀的部分。主席會在這篇文章裏總結一些主要的財務數據，比如銷售額、盈利、客戶情況、股息等等。除此之外，也會重點介紹過去一年的企業活動、戰略、","listText":"投資者爲什麼一定要會看財報？直接出錢投資不就好了嗎？如果你也抱着同樣的想法，對每個季度發佈的季報和每年發佈的年報視若無睹的話，你可能虧了錢都不知道爲什麼錢會沒了。財報，顯示了公司的財務和經營狀況。你不認識公司的CEO或管理層沒關係，至少你要學會通過分析財報來了解公司當下的發展狀況和成長空間，才能決定是否投資、投資更多，或者是及早離場。但是，密密麻麻的文字和數字，應該看什麼、怎麼看？今天，教你幾招掌握閱讀財報的技巧。上市公司必須按季度定期披露公司的經營情況，所以就有第一季度、第二季度（中期報告）、第三季度和第四季度。通常在公佈第四季度的同時，也會總結一整年的統計數據。從內容來看，季報會比較簡單，多數都會包含資產負債表、損益表和現金流量表三大報表。但是，有些公司會選擇不披露現金流量數據，這也很正常。年報是總結了一整年業績後所呈現給股東的報告。年報是經過會計師事務所審計過的，季報裏任何誤差會在年報裏糾正，所以可信程度上是最高的，提供的資料信息也是最全面的。【財報的時間】首先，大家必須知道每家公司的財政年度未必都是1月至12月。因此，要知道公司什麼時候會公佈季報或年報，投資者就得先了解公司的財政年度。舉個例子，如果公司的財政年度是2月至隔年1月，公司第一季度的財報涵蓋的就是2月至4月的業績報告，以此類推。每個季度結束後，公司有多少時間準備財報呢？每個國家的證監會給予上市公司遞交財報的時限略有不同，多數介於1-3個月之間。以美股爲例，美國證監會要求上市3年以上的公司，必須在每個季度結束後的35天之內遞交季度財報，在財政年度結束後的60天內遞交年報。【財報看點】1. 主席致辭 (Chairman’s Statement)「主席致辭」是年報裏應該重點閱讀的部分。主席會在這篇文章裏總結一些主要的財務數據，比如銷售額、盈利、客戶情況、股息等等。除此之外，也會重點介紹過去一年的企業活動、戰略、","text":"投資者爲什麼一定要會看財報？直接出錢投資不就好了嗎？如果你也抱着同樣的想法，對每個季度發佈的季報和每年發佈的年報視若無睹的話，你可能虧了錢都不知道爲什麼錢會沒了。財報，顯示了公司的財務和經營狀況。你不認識公司的CEO或管理層沒關係，至少你要學會通過分析財報來了解公司當下的發展狀況和成長空間，才能決定是否投資、投資更多，或者是及早離場。但是，密密麻麻的文字和數字，應該看什麼、怎麼看？今天，教你幾招掌握閱讀財報的技巧。上市公司必須按季度定期披露公司的經營情況，所以就有第一季度、第二季度（中期報告）、第三季度和第四季度。通常在公佈第四季度的同時，也會總結一整年的統計數據。從內容來看，季報會比較簡單，多數都會包含資產負債表、損益表和現金流量表三大報表。但是，有些公司會選擇不披露現金流量數據，這也很正常。年報是總結了一整年業績後所呈現給股東的報告。年報是經過會計師事務所審計過的，季報裏任何誤差會在年報裏糾正，所以可信程度上是最高的，提供的資料信息也是最全面的。【財報的時間】首先，大家必須知道每家公司的財政年度未必都是1月至12月。因此，要知道公司什麼時候會公佈季報或年報，投資者就得先了解公司的財政年度。舉個例子，如果公司的財政年度是2月至隔年1月，公司第一季度的財報涵蓋的就是2月至4月的業績報告，以此類推。每個季度結束後，公司有多少時間準備財報呢？每個國家的證監會給予上市公司遞交財報的時限略有不同，多數介於1-3個月之間。以美股爲例，美國證監會要求上市3年以上的公司，必須在每個季度結束後的35天之內遞交季度財報，在財政年度結束後的60天內遞交年報。【財報看點】1. 主席致辭 (Chairman’s Statement)「主席致辭」是年報裏應該重點閱讀的部分。主席會在這篇文章裏總結一些主要的財務數據，比如銷售額、盈利、客戶情況、股息等等。除此之外，也會重點介紹過去一年的企業活動、戰略、","images":[{"img":"https://static.tigerbbs.com/08fcfde3cc5a7a8d6b08e442d2d7d9ff"},{"img":"https://static.tigerbbs.com/d22546566003092fb4ff75f87eeeef5c"},{"img":"https://static.tigerbbs.com/908edf3e8532a37de64032bd55e4a573"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813432346","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187217517,"gmtCreate":1623755293239,"gmtModify":1704210638390,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187217517","repostId":"1167457915","repostType":4,"repost":{"id":"1167457915","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1623750756,"share":"https://www.laohu8.com/m/news/1167457915?lang=&edition=full","pubTime":"2021-06-15 17:52","market":"us","language":"en","title":"Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1167457915","media":"Benzinga","summary":"It was \"better late than never\" for Novavax, Inc.NVAX, as the biopharma finally got around to announ","content":"<p>It was \"better late than never\" for&nbsp;<b>Novavax, Inc.</b>NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.</p>\n<p>Here's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namely<b>Pfizer Inc.</b>PFE 0.05%-<b>BioNTech SE</b>BNTXand<b>Moderna, Inc.</b>MRNA, both of which have authorized vaccines in the market.</p>\n<p><b>Vaccine Type:</b>&nbsp;Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.</p>\n<p>The Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern&nbsp;vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.</p>\n<p>This spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.</p>\n<p>Novavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle&nbsp;that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.</p>\n<p><b>The Vaccine Doses:</b>&nbsp;The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.</p>\n<p>The interval between the two doses —&nbsp;the priming and booster dose —&nbsp;is 21 days each for Pfizer and Novavax and 28 days for Moderna.</p>\n<p><b>The Target Population:</b>&nbsp;The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants&nbsp;ages 16 years and older. The trial enrolled 43,448 participants.</p>\n<p>Moderna'sPhase 3 COVE study enrolled 30,000 participants&nbsp;ages 18 years and up.</p>\n<p>Since then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.</p>\n<p>Bothcompanieshave also initiated studies in the pediatric population.</p>\n<p>Novavax's study enrolled 29,960 participants&nbsp;18 years of age and older&nbsp;across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.</p>\n<p><b>Vaccine Logistics:</b>&nbsp;Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.</p>\n<p>Previously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five&nbsp;days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.</p>\n<p>NVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.</p>\n<p><b>Vaccine Efficacy:</b>&nbsp;Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven&nbsp;days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.</p>\n<p>The vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.</p>\n<p>Moderna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.</p>\n<p>Novavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.</p>\n<p>Against variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.</p>\n<p>Overall efficacy was 90.4%, meeting the primary endpoint.</p>\n<p><b>Cantor Fitzgerald On Novavax's Vaccine:</b>A differentiating factor for NVX-2373&nbsp;is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.</p>\n<p>\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.</p>\n<p>Showing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.</p>\n<p>This profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.</p>\n<p><b>Vaccine Safety Data:</b>Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from&nbsp;BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.</p>\n<p>For Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.</p>\n<p>Preliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.</p>\n<p>In assessing reactogenicity seven&nbsp;days after dose one&nbsp;and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-06-15 17:52</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>It was \"better late than never\" for&nbsp;<b>Novavax, Inc.</b>NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.</p>\n<p>Here's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namely<b>Pfizer Inc.</b>PFE 0.05%-<b>BioNTech SE</b>BNTXand<b>Moderna, Inc.</b>MRNA, both of which have authorized vaccines in the market.</p>\n<p><b>Vaccine Type:</b>&nbsp;Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.</p>\n<p>The Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern&nbsp;vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.</p>\n<p>This spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.</p>\n<p>Novavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle&nbsp;that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.</p>\n<p><b>The Vaccine Doses:</b>&nbsp;The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.</p>\n<p>The interval between the two doses —&nbsp;the priming and booster dose —&nbsp;is 21 days each for Pfizer and Novavax and 28 days for Moderna.</p>\n<p><b>The Target Population:</b>&nbsp;The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants&nbsp;ages 16 years and older. The trial enrolled 43,448 participants.</p>\n<p>Moderna'sPhase 3 COVE study enrolled 30,000 participants&nbsp;ages 18 years and up.</p>\n<p>Since then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.</p>\n<p>Bothcompanieshave also initiated studies in the pediatric population.</p>\n<p>Novavax's study enrolled 29,960 participants&nbsp;18 years of age and older&nbsp;across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.</p>\n<p><b>Vaccine Logistics:</b>&nbsp;Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.</p>\n<p>Previously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five&nbsp;days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.</p>\n<p>NVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.</p>\n<p><b>Vaccine Efficacy:</b>&nbsp;Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven&nbsp;days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.</p>\n<p>The vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.</p>\n<p>Moderna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.</p>\n<p>Novavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.</p>\n<p>Against variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.</p>\n<p>Overall efficacy was 90.4%, meeting the primary endpoint.</p>\n<p><b>Cantor Fitzgerald On Novavax's Vaccine:</b>A differentiating factor for NVX-2373&nbsp;is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.</p>\n<p>\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.</p>\n<p>Showing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.</p>\n<p>This profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.</p>\n<p><b>Vaccine Safety Data:</b>Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from&nbsp;BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.</p>\n<p>For Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.</p>\n<p>Preliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.</p>\n<p>In assessing reactogenicity seven&nbsp;days after dose one&nbsp;and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167457915","content_text":"It was \"better late than never\" for Novavax, Inc.NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.\nHere's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namelyPfizer Inc.PFE 0.05%-BioNTech SEBNTXandModerna, Inc.MRNA, both of which have authorized vaccines in the market.\nVaccine Type: Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.\nThe Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.\nThis spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.\nNovavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.\nThe Vaccine Doses: The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.\nThe interval between the two doses — the priming and booster dose — is 21 days each for Pfizer and Novavax and 28 days for Moderna.\nThe Target Population: The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants ages 16 years and older. The trial enrolled 43,448 participants.\nModerna'sPhase 3 COVE study enrolled 30,000 participants ages 18 years and up.\nSince then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.\nBothcompanieshave also initiated studies in the pediatric population.\nNovavax's study enrolled 29,960 participants 18 years of age and older across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.\nVaccine Logistics: Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.\nPreviously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.\nNVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.\nVaccine Efficacy: Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.\nThe vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.\nModerna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.\nNovavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.\nAgainst variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.\nOverall efficacy was 90.4%, meeting the primary endpoint.\nCantor Fitzgerald On Novavax's Vaccine:A differentiating factor for NVX-2373 is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.\n\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.\nShowing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.\nThis profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.\nVaccine Safety Data:Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.\nFor Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.\nPreliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.\nIn assessing reactogenicity seven days after dose one and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":382483058,"gmtCreate":1613475233074,"gmtModify":1704880880940,"author":{"id":"3556860469908509","authorId":"3556860469908509","name":"lolilo2107","avatar":"https://static.tigerbbs.com/a081eb4b72b47ad2caa28922629491f9","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Coin","listText":"Coin","text":"Coin","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/382483058","repostId":"1114634078","repostType":4,"isVote":1,"tweetType":1,"viewCount":76,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}